Organic light emitting device

By integrating deuterated Formula 1 and asymmetric Formula 2 compounds in the organic layers, the device achieves enhanced efficiency, lifespan, and reduced driving voltage, addressing the limitations of existing OLED materials.

KR103046376B1Active Publication Date: 2026-11-10LG CHEM LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
KR1020240111179
Authority / Receiving Office
KR · KR
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-11-27
Filing Date
2024-08-20
Publication Date
2026-11-10
Estimated Expiration
2039-11-27

AI Technical Summary

Technical Problem

Existing organic light-emitting devices face challenges in achieving low driving voltage, high efficiency, and long lifespan, particularly in the development of new materials for organic layers.

Method used

Incorporating a compound represented by Chemical Formula 1 in a first organic layer and a compound represented by Chemical Formula 2 in a second organic layer, where Formula 1 is deuterated by at least 40% and Formula 2 features an asymmetric structure with a heterocyclic ring, enhancing electron injection and stability.

Benefits of technology

The organic light-emitting device exhibits improved efficiency, lifespan, and reduced driving voltage due to the use of deuterated Formula 1 and asymmetric Formula 2, which stabilize the organic layers and enhance electron injection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 112024090541447-PAT00294_ABST
    Figure 112024090541447-PAT00294_ABST
Patent Text Reader

Abstract

The present specification provides an organic light-emitting device comprising a first organic layer and a second organic layer.
Need to check novelty before this filing date? Find Prior Art

Description

Technology Field

[0001] This specification relates to organic light-emitting diodes.

[0002] This application claims the benefit of the filing date of Korean Patent Application No. 10-2018-0148350 filed with the Korean Intellectual Property Office on November 27, 2018, the entire contents of which are incorporated herein. Background Technology

[0003] Generally, organic light emission refers to the phenomenon of converting electrical energy into light energy using organic materials. Organic light-emitting devices (OLEDs) that utilize this phenomenon typically have a structure comprising an anode, a cathode, and an organic layer between them. Here, the organic layer is often composed of a multilayer structure made of different materials to enhance the efficiency and stability of the OLED; for example, it may consist of a hole injection layer, a hole transport layer, an emissive layer, an electron transport layer, and an electron injection layer. In the structure of such an OLED, when a voltage is applied between the two electrodes, holes are injected into the organic layer from the anode and electrons from the cathode. When the injected holes and electrons meet, excitons are formed, and light is emitted when these excitons fall back to the ground state.

[0004] The development of new materials for organic light-emitting devices as described above is continuously required. Prior art literature

[0005] International Patent Application Publication No. 2003 / 012890

[0006] Kei Sakanoue, J. Phys. Chem. A 1999, 103, 5551-5556, The problem to be solved

[0007] The present specification aims to provide an organic light-emitting device having a low driving voltage, high efficiency, excellent lifespan characteristics, or high color purity by including a compound represented by Chemical Formula 1 in a first organic layer and a compound represented by Chemical Formula 2 in a second organic layer. means of solving the problem

[0008] The present specification describes an organic light-emitting device comprising an anode; a cathode; and a first organic layer and a second organic layer provided between the anode and the cathode,

[0009] The first organic layer comprises a compound represented by the following chemical formula 1, and

[0010] The above second organic layer comprises a compound represented by the following chemical formula 2, thereby providing an organic light-emitting device.

[0011] [Chemical Formula 1]

[0012]

[0013] In the above chemical formula 1,

[0014] L101 and L102 are identical or different from each other, and each is independently a directly bonded; a substituted or unsubstituted arylene group; or a substituted or unsubstituted heteroarylene group, and

[0015] R11 to R18 are identical or different from one another, and each independently is hydrogen; deuterium; a substituted or unsubstituted alkyl group; a substituted or unsubstituted cycloalkyl group; a substituted or unsubstituted silyl group; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heteroaryl group, or adjacent substituents are combined to form a substituted or unsubstituted ring, and

[0016] Ar101 and Ar102 are identical or different from each other and are each independently substituted or unsubstituted aryl groups; or are substituted or unsubstituted heteroaryl groups, or are connected to adjacent substituents to form a substituted or unsubstituted ring, and

[0017] m1 and m2 are integers from 0 to 5, and

[0019] If m1 is 2 or more, L101 are identical or different from each other, and

[0020] If m2 is 2 or more, L102 are identical or different from each other, and

[0021] The compound represented by the above chemical formula 1 is deuterated by at least 40%, and

[0022] [Chemical Formula 2]

[0023]

[0024] In the above chemical formula 2,

[0025] Y is O; or S,

[0026] R21 to R24 are identical or different from one another and are each independently hydrogen; deuterium; a nitrile group; a substituted or unsubstituted alkyl group; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heterocyclic group, represented by the following chemical formula 3, or adjacent substituents are bonded to each other to form a substituted or unsubstituted ring, and

[0027] At least one of R21 and R22 is represented by the following chemical formula 3, and

[0028] r21 to r24 are identical or different from each other and are each independently integers from 0 to 4, and if r21 is 2 or more, R21 are identical or different from each other, if r22 is 2 or more, R22 are identical or different from each other, if r23 is 2 or more, R23 are identical or different from each other, and if r24 is 2 or more, R24 are identical or different from each other, and

[0029] [Chemical Formula 3]

[0030]

[0031] In the above chemical formula 3,

[0032] X1 is N or C(R31), X2 is N or C(R32), X3 is N or C(R33), and at least one of X1 to X3 is N, and

[0033] R31, R32, and R33 are identical or different from one another, and each independently is hydrogen; a deuterium-substituted or unsubstituted aryl group; or a substituted or unsubstituted heterocyclic group, or combines with Ar1 or Ar2 to form a substituted or unsubstituted aromatic hydrocarbon ring; or a substituted or unsubstituted heterocyclic group, and

[0034] Ar1 and Ar2 are identical or different from each other, and each is independently an aryl group substituted or unsubstituted with R41; or a heterocyclic ring substituted or unsubstituted with R42, or an aromatic hydrocarbon ring substituted or unsubstituted by combining with R31, R32 or R33; or forms a substituted or unsubstituted heterocyclic ring, and

[0035] R41 and R42 are identical or different from each other, and each is independently selected from the group consisting of deuterium; halogen group; nitrile group; alkyl group; haloalkyl group; alkoxy group; silyl group; aryl group; and heterocyclic group, or has two or more substituents connected thereto,

[0036] L is a directly bonded; a substituted or unsubstituted arylene group; or a substituted or unsubstituted divalent heterocyclic group, and

[0037] m is an integer from 0 to 4, and if m is 2 or greater, L are the same or different from each other, and

[0038] * is the site that binds to chemical formula 2. Effects of the invention

[0039] An organic light-emitting device according to one embodiment of the present specification comprises a compound of Formula 1 and a compound of Formula 2, and has excellent long lifespan characteristics, high efficiency characteristics, and low driving voltage. Brief explanation of the drawing

[0040] FIGS. 1 to 4 illustrate examples of organic light-emitting devices of the present invention. Specific details for implementing the invention

[0041] The present specification is described in more detail below. However, the following description relates to one embodiment of the present invention and includes all substitutable ranges within an equivalent range.

[0042] First, some terms in this specification are clarified.

[0043] In this specification, when a part is described as "comprising" a certain component, this means that, unless specifically stated otherwise, it does not exclude other components but may include additional components.

[0044] In this specification, Cn refers to n carbon atoms.

[0045] In this specification, Cn1-Cn2 refers to a carbon atom having n1 to n2 atoms.

[0046] In this specification, Dn refers to n deuterium atoms.

[0047] Examples of substituents in this specification are described below, but are not limited thereto.

[0048] The term "substitution" above means that a hydrogen atom bonded to a carbon atom of a compound is replaced with another substituent, and the substitution site is not limited to the site where the hydrogen atom is substituted, that is, any site where a substituent can be substituted, and in the case of two or more substitutions, the two or more substituents may be the same or different from each other.

[0049] In this specification, the term “substituted or unsubstituted” means that it is substituted with one or more substituents selected from the group consisting of deuterium; halogen group; nitrile group; alkyl group; haloalkyl group; alkoxy group; haloalkoxy group; cycloalkyl group; silyl group; alkenyl group; amine group; arylamine group; aryl group; and heterocyclic groups comprising one or more atoms of N, O, S, Se, and Si, or is substituted with a substituent in which two or more of the exemplified substituents are connected, or has no substituents. For example, “a substituent in which two or more substituents are connected” may be a biphenyl group. That is, the biphenyl group may be an aryl group, or it may be interpreted as a substituent in which two phenyl groups are connected.

[0050] In this specification, the connection of two or more substituents means that a hydrogen of one substituent is connected to another substituent. For example, an isopropyl group and a phenyl group are connected or It can be a substituent of.

[0051] In this specification, the connection of three substituents includes not only the connection of (substituent 1)-(substituent 2)-(substituent 3) in succession, but also the connection of (substituent 2) and (substituent 3) to (substituent 1). For example, two phenyl groups and isopropyl groups are connected or It can be a substituent. The same applies to the connection of 4 or more substituents as described above.

[0052] In this specification, * or means a site that is bonded to another substituent or bonding site.

[0053] In one embodiment of the present specification, “substituted or unsubstituted” means substituted with one or more substituents from the group consisting of deuterium; halogen group; nitrile group; C1-C20 alkyl group; C1-C20 haloalkyl group; C1-C20 alkoxy group; C1-C20 haloalkoxy group; C3-C20 cycloalkyl group; C1-C50 silyl group; C2-C20 alkenyl group; amine group; C6-C50 arylamine group; C6-C30 aryl group; and C2-C30 heterocyclic groups comprising one or more atoms of N, O, S, Se, and Si, or substituted with a substituent in which two or more substituents are connected, or not having any substituents.

[0054] In one embodiment of the present specification, “substituted or unsubstituted” means substituted with one substituent selected from the group consisting of deuterium, C1-C10 alkyl groups, C6-C30 aryl groups and C2-C30 heterocyclic groups, or with a substituent formed by connecting two or more substituents, or having no substituents.

[0055] In this specification, examples of halogen groups include fluorine, chlorine, bromine, or iodine.

[0056] In the present specification, the alkyl group may be a straight chain or a branched chain, and the number of carbon atoms is not particularly limited, but is preferably 1 to 30; 1 to 20; 1 to 10; or 1 to 5. Specific examples include, but are not limited to, methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, tert-butyl, sec-butyl, 1-methylbutyl, 1-ethylbutyl, pentyl, n-pentyl, isopentyl, neopentyl, tert-pentyl, hexyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3,3-dimethylbutyl, 2-ethylbutyl, heptyl, n-heptyl, 1-methylhexyl, cyclopentylmethyl, cyclohexylmethyl, octyl, n-octyl, tert-octyl, 1-methylheptyl, 2-ethylhexyl, 2-propylpentyl, n-nonyl, 2,2-dimethylheptyl, 1-ethylpropyl, 1,1-dimethylpropyl, isohexyl, 4-methylhexyl, 5-methylhexyl.

[0057] In this specification, the haloalkyl group may be a straight chain or a branched chain, and refers to a group in which a hydrogen of the aforementioned alkyl group is substituted with one or more halogen groups. The number of carbon atoms is not particularly limited, but is preferably 1 to 30; 1 to 20; 1 to 10; or 1 to 5. The description of the aforementioned alkyl group may apply to the alkyl group. Specific examples of haloalkyl groups include, but are not limited to, fluoromethyl groups, difluoromethyl groups, trifluoromethyl groups, chloromethyl groups, dichloromethyl groups, trichloromethyl groups, bromomethyl groups, dibromomethyl groups, tribromomethyl groups, etc.

[0058] In the present specification, the cycloalkyl group is not particularly limited, but is preferably 3 to 60 carbon atoms, and more preferably 3 to 30; 3 to 15; or 3 to 6. Specifically, examples include cyclopropyl, cyclobutyl, cyclopentyl, 3-methylcyclopentyl, 2,3-dimethylcyclopentyl, cyclohexyl, 3-methylcyclohexyl, 4-methylcyclohexyl, 2,3-dimethylcyclohexyl, 3,4,5-trimethylcyclohexyl, 4-tert-butylcyclohexyl, cycloheptyl, cyclooctyl, etc., but are not limited thereto.

[0059] In this specification, the alkoxy group is formed by connecting an alkyl group to an oxygen atom and may be a straight chain, a branched chain, or a cyclic chain. The number of carbon atoms in the alkoxy group is not particularly limited, but is preferably 1 to 30; 1 to 20; 1 to 10; or 1 to 5. Specifically, it may be methoxy, ethoxy, n-propoxy, isopropoxy, i-propyloxy, n-butoxy, isobutoxy, tert-butoxy, sec-butoxy, n-pentyloxy, neopentyloxy, isopentyloxy, n-hexyloxy, 3,3-dimethylbutyloxy, 2-ethylbutyloxy, n-octyloxy, n-nonyloxy, n-decyloxy, benzyloxy, p-methylbenzyloxy, etc., but is not limited thereto.

[0060] In the present specification, the alkenyl group may be a straight chain or a branched chain, and the number of carbon atoms is not particularly limited, but is preferably 2 to 30; 2 to 20; 2 to 10; or 2 to 5. Specific examples include vinyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 3-methyl-1-butenyl, 1,3-butadienyl, allyl, 1-phenylvinyl-1-yl, 2-phenylvinyl-1-yl, 2,2-diphenylvinyl-1-yl, 2-phenyl-2-(naphthyl-1-yl)vinyl-1-yl, 2,2-bis(diphenyl-1-yl)vinyl-1-yl, stilbenyl group, styrenyl group, etc., but are not limited thereto.

[0061] In the present specification, the silyl group may be represented by the chemical formula -SiRaRbRc, and Ra, Rb, and Rc may each be hydrogen; a substituted or unsubstituted alkyl group; or a substituted or unsubstituted aryl group. Specifically, the silyl group may be a trimethylsilyl group, a triethylsilyl group, a tert-butyldimethylsilyl group, a vinyldimethylsilyl group, a propyldimethylsilyl group, a triphenylsilyl group, a diphenylsilyl group, a phenylsilyl group, etc., but is not limited thereto.

[0062] In the present specification, the amine group may be represented by the chemical formula -NRfRg, and Rf and Rg may each be hydrogen; deuterium; a substituted or unsubstituted alkyl group; a substituted or unsubstituted cycloalkyl group; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heterocyclic group. The amine group may be selected from the group consisting of alkylamine groups; arylalkylamine groups; arylamine groups; arylheteroarylamine groups; alkylheteroarylamine groups; and heteroarylamine groups, and more specifically may be a dimethylamine group; a diphenylamine group; etc., but is not limited thereto.

[0063] In this specification, an aryl group refers to a monovalent group of a monovalent aromatic hydrocarbon or an aromatic hydrocarbon derivative. In this specification, an aromatic hydrocarbon refers to a compound comprising a planar ring in which pi electrons are fully conjugated, and a group derived from an aromatic hydrocarbon refers to a structure in which an aromatic hydrocarbon or a cyclic aliphatic hydrocarbon is condensed to an aromatic hydrocarbon. Furthermore, in this specification, an aryl group is intended to include a monovalent group in which two or more aromatic hydrocarbons or derivatives of aromatic hydrocarbons are connected to each other. The aryl group is not particularly limited, but it is preferred to have 6 to 50 carbon atoms; 6 to 30; 6 to 25; 6 to 20; 6 to 18; or 6 to 13 carbon atoms, and the aryl group may be monocyclic or polycyclic. Specifically, monocyclic aryl groups may include phenyl groups, biphenyl groups, terphenyl groups, etc., but are not limited thereto. Specifically, polycyclic aryl groups may include naphthyl groups, anthracenyl groups, phenanthryl groups, triphenyl groups, pyrenyl groups, perylenyl groups, chrysenyl groups, fluorenyl groups, etc., but are not limited thereto.

[0064] In the present specification, the fluorenyl group may be substituted, and adjacent substituents may combine with each other to form a ring.

[0065] In this specification, when it is stated that a fluorenyl group may be substituted, the substituted fluorenyl group includes all compounds in which the substituents of the 5-membered ring of fluorene are spiro-bonded to each other to form an aromatic hydrocarbon ring. The substituted fluorenyl group includes, but is not limited to, 9,9'-spirobifluorene, spiro[cyclopentane-1,9'-fluorene], spiro[benzo[c]fluorene-7,9-fluorene], etc.

[0066] In this specification, a heteroaryl group refers to a monovalent aromatic heterocycle. Here, an aromatic heterocycle refers to a monovalent group of an aromatic ring or a derivative of an aromatic ring, comprising one or more heteroatoms among N, O, S, and Si in the ring. The derivative of the aromatic ring includes all structures in which an aromatic ring or an aliphatic ring is condensed to an aromatic ring. Furthermore, in this specification, the heteroaryl group is intended to comprise a monovalent group in which an aromatic ring containing two or more heteroatoms or a derivative of an aromatic ring containing heteroatoms is connected to one another. It is preferable that the number of carbon atoms of the heteroaryl group be 2 to 50; 2 to 30; 2 to 20; 2 to 18; or 2 to 13.

[0067] Examples of heteroaryl groups include thiophene group, furan group, pyrrole group, imidazole group, thiazole group, oxazole group, oxadiazole group, triazole group, pyridine group, bipyridine group, pyrimidine group, triazine group, acridine group, pyridazine group, pyrazine group, quinoline group, quinazolin group, quinoxaline group, phthalazine group, pteridine group, pyridopyrimidine group, pyridopyrazine group, pyrazinopyrazine group, isoquinoline group, indole group, pyridoindole group, 5H-indenopyrimidine, carbazole group, benzoxazole group, benzimidazole group, benzothiazole group, Benzocarbazole group, benzothiophen group, dibenzothiophen group, benzofuran group, dibenzofuran group, dibenzosilole group, phenanthroline group, thiazolyl group, isooxazolyl group, oxadiazoyl group and thiadiazolyl group, etc., are included but are not limited to these.

[0068] In this specification, an arylene group refers to a group having two binding sites to an aryl group, i.e., a divalent group. Except for the fact that each of these is a divalent group, the description of the aryl group described above may apply.

[0069] In this specification, a heteroarylene group refers to a heteroaryl group having two binding sites, i.e., a divalent group. Except for the fact that each of these is a divalent group, the description of the heteroaryl group described above may apply.

[0070] In this specification, "adjacent" groups may mean a substituent substituted on an atom directly connected to the atom on which the substituent is substituted, a substituent located closest to the atom on which the substituent is substituted, or another substituent substituted on the atom on which the substituent is substituted. For example, two substituents substituted at the ortho position in a benzene ring and two substituents substituted on the same carbon in an aliphatic ring may be interpreted as "adjacent" groups to each other.

[0071] In the present specification, in a substituted or unsubstituted ring formed by combining adjacent groups, "ring" means a substituted or unsubstituted hydrocarbon ring; or a substituted or unsubstituted heteroring.

[0072] In this specification, the hydrocarbon ring may be an aromatic, aliphatic, or aromatic and aliphatic condensation ring, and may be selected from the examples of the cycloalkyl group or aryl group except that it is not monovalent. Examples of aromatic and aliphatic condensation rings include, but are not limited to, 1,2,3,4-tetrahydronaphthalene group, 2,3-dihydro-1H-indene group, etc.

[0073] In the present specification, the aromatic ring may be monocyclic or polycyclic and may be selected from the examples of the aryl group except that it is not monovalent.

[0074] In the present specification, the heterocycle comprises one or more atoms other than carbon or heteroatoms, and specifically, the heteroatoms may comprise one or more atoms selected from the group consisting of O, N, S, and Si, etc. The heterocycle may be monocyclic or polycyclic, may be an aromatic, aliphatic, or aromatic and aliphatic condensation ring, and may be selected from the examples of heteroaryl groups except that it is not monovalent.

[0075] Formulas 1 and 2 of the present specification include being substituted with deuterium even when the substituted substituent is not specified.

[0076] Hereinafter, an organic light-emitting element and a compound included therein according to one embodiment of the present specification will be described.

[0077] The present specification provides an organic light-emitting device comprising an anode; a cathode; and a first organic layer and a second organic layer provided between the anode and the cathode, wherein the first organic layer comprises a compound represented by Chemical Formula 1 and the second organic layer comprises a compound represented by Chemical Formula 2.

[0078] The compound represented by Chemical Formula 1 above contains deuterium. When hydrogen is replaced with deuterium, the chemical properties of the compound hardly change. However, since the atomic weight of deuterium is twice that of hydrogen, the physical properties of the deuteriumized compound may change. For example, the vibrational energy level of a compound substituted with deuterium is lowered. A compound substituted with deuterium can prevent a decrease in quantum efficiency caused by a reduction in intermolecular van der Waals forces or collisions due to intermolecular vibrations. Additionally, CD bonding can improve the stability of the compound. Accordingly, the compound represented by Chemical Formula 1 can improve the efficiency and lifespan of the device by including deuterium.

[0079] In this specification, “deuterated” means that hydrogen is substituted with deuterium. An N% deuterated compound or group means that N% of the available hydrogen is substituted with deuterium. Substituting N% of the hydrogen of a group with deuterium means that N% of the total number of substitutable hydrogens, excluding the positions where the substituent is connected to the parent structure, is substituted with deuterium (D). For example, substituting 20% ​​of the hydrogen of a phenyl group with deuterium means that 1 hydrogen, which is 20% of the 5 substitutable hydrogens of the phenyl group, is substituted with deuterium (D). Substituting 33% of the hydrogen of a biphenyl group with deuterium means that 3 hydrogens are substituted with deuterium.

[0080] In one embodiment of the present specification, the deuterated compound may be prepared by a known deuteration reaction. According to one embodiment of the present specification, the compound represented by Formula 1 may be formed using a deuterated compound as a precursor, or deuterium may be introduced into the compound through a hydrogen-deuterium exchange reaction under an acid catalyst using a deuterated solvent.

[0081] In this specification, the degree of deuteration is determined by nuclear magnetic resonance spectroscopy ( 1 It can be confirmed by known methods such as 1H NMR or GC / MS.

[0082] The compound represented by Chemical Formula 2 above has a structure in which a heterocyclic ring containing one or more N is connected to a spiro-type ring containing O or S. The spiro-type ring containing O or S causes steric hindrance in the compound. This steric hindrance prevents crystallization during film formation and increases thermal stability, allowing the layer to be formed stably even at high deposition temperatures. In one embodiment, when the compound represented by Chemical Formula 2 is used in an organic layer, an increase in the device lifespan can be expected due to high thermal stability and processability. Additionally, high efficiency of the device can be expected by having a heterocyclic ring containing one or more N as a substituent.

[0083] In the compound represented by the above chemical formula 2, it is not a symmetric structure (i.e., a structure in which R21 and R22; or R23 and R24 simultaneously include the structure of chemical formula 3). That is, it includes the structure of chemical formula 3 asymmetrically. In this case, the dipole moment of the molecule is improved due to the asymmetric structure of chemical formula 2. Accordingly, when the compound included in chemical formula 2 is included in an organic layer (e.g., an electron transport layer) between the cathode and the light-emitting layer, the electron injection rate into the light-emitting layer is increased, which can lower the driving voltage of the organic light-emitting device. In addition, due to the asymmetric structure, the degree of crystallization in the solution state is lowered, so economic effects can be expected in terms of time and / or cost when forming the organic layer.

[0084] The value of the dipole moment of the compound represented by Formula 2 according to one embodiment of the present specification is 0.6 debye or greater. The value of the dipole moment may be attributed to structural characteristics.

[0085] In this specification, the dipole moment is a physical quantity representing the degree of polarity and can be calculated by the following mathematical formula 1.

[0086] [Mathematical Formula 1]

[0087]

[0088] The value of the dipole moment can be obtained by calculating the molecular density from the above mathematical formula 1. For example, the molecular density can be obtained by calculating the charge and dipole for each atom using a method called Hirshfeld Charge Analysis, and then calculating it according to the following formula.

[0089]

[0090]

[0091]

[0092] As mentioned above, the compound of Formula 2 is an excellent material with an excellent electron injection effect due to its asymmetric structure. When the compound of Formula 1 is used as a host for the light-emitting layer, its electron-accepting ability is excellent, and stability is improved. Therefore, the efficiency and lifespan of an organic light-emitting device containing the compound of Formula 1 and the compound of Formula 2 are excellent.

[0093] In one embodiment of the present specification, the compound represented by Formula 1 is deuterated by at least 40%. In one embodiment, the compound represented by Formula 1 is deuterated by at least 50%. In one embodiment, the compound represented by Formula 1 is deuterated by at least 60%. In one embodiment, the compound represented by Formula 1 is deuterated by at least 70%. In one embodiment, the compound represented by Formula 1 is deuterated by at least 80%. In one embodiment, the compound represented by Formula 1 is deuterated by at least 90%. In one embodiment, the compound represented by Formula 1 is deuterated by 100%.

[0094] In one embodiment of the present specification, the formula 1 comprises at least one hydrogen.

[0095] In one embodiment of the present specification, L101 and L102 are identical or different from each other and are each independently directly bonded; a substituted or unsubstituted arylene group; or a substituted or unsubstituted heteroarylene group.

[0096] In one embodiment of the present specification, L101 and L102 are identical or different from each other and are each independently directly bonded; a substituted or unsubstituted C6-C30 arylene group; or a C2-C30 heteroarylene group.

[0097] In one embodiment of the present specification, L101 and L102 are identical or different from each other and are each independently a direct bond; a C6-C20 arylene group; or a C2-C20 heteroarylene group comprising N, O, or S. The arylene group or heteroarylene group is substituted or unsubstituted with a C1-C10 alkyl group, a C6-C20 aryl group, or a C2-C20 heteroaryl group.

[0098] In one embodiment of the present specification, L101 and L102 are identical or different from each other and are each independently direct bonded; a C6-C20 arylene group substituted or unsubstituted with a C1-C10 alkyl group; or a C2-C20 heteroarylene group comprising N, O or S.

[0099] In one embodiment of the present specification, L101 and L102 are identical or different from each other and are each independently directly bonded; a substituted or unsubstituted phenylene group; a substituted or unsubstituted biphenyl group; a substituted or unsubstituted terphenylene group; a substituted or unsubstituted naphthylene group; a substituted or unsubstituted fluorenylene group; a substituted or unsubstituted anthracenylene group; a substituted or unsubstituted phenanthrenylene group; a substituted or unsubstituted spirobifluorenylene group; a substituted or unsubstituted dicarbazole group; a substituted or unsubstituted dibenzofuran group; a substituted or unsubstituted dibenzothiophen group; a substituted or unsubstituted diquinoline group; a substituted or unsubstituted dipyridine group; a substituted or unsubstituted dipyrimidine group; or a substituted or unsubstituted divalent triazine group. In another embodiment, the term "substituted or unsubstituted" refers to being substituted with an alkyl group having 1 to 5 carbon atoms; an aryl group having 6 to 20 carbon atoms; or a heterocyclic group having 2 to 20 carbon atoms, or not having any substituent.

[0100] In one embodiment of the present specification, L101 and L102 are identical or different from each other and are each independently directly bonded; a substituted or unsubstituted phenylene group; a substituted or unsubstituted biphenyl group; a substituted or unsubstituted naphthylene group; a substituted or unsubstituted dibenzofuran group; a substituted or unsubstituted dibenzothiophen group; a substituted or unsubstituted divalent pyridine group; a substituted or unsubstituted diquinoline group; or a substituted or unsubstituted diquinoline group.

[0101] In one embodiment of the present specification, L101 and L102 are identical or different from each other and are each independently directly bonded; or are C6-C20 arylene groups substituted or unsubstituted with C1-C10 alkyl groups.

[0102] In one embodiment of the present specification, L101 and L102 are identical or different from each other and are each independently directly bonded; or are C6-C20 arylene groups.

[0103] In one embodiment of the present specification, L101 and L102 are identical or different from each other and are each independently direct bonded; a phenylene group substituted or unsubstituted with a propyl group; a biphenyl group; a naphthylene group; a divalent dibenzofuran group; a divalent pyridine group; or a divalent quinoline group.

[0104] In one embodiment of the present specification, L101 and L102 are different from each other.

[0105] In one embodiment of the present specification, the L101 is dehydrogenated by 40% or more; 50% or more; 60% or more; 70% or more; 80% or more; 90% or more; or 100%.

[0106] In one embodiment of the present specification, the L102 is dehydrogenated by 40% or more; 50% or more; 60% or more; 70% or more; 80% or more; 90% or more; or 100%.

[0107] In one embodiment of the present specification, one of L101 and L102 is a direct bond, and the other is a substituted or unsubstituted C6-C20 arylene group.

[0108] In one embodiment of the present specification, L101 and L102 are each directly coupled.

[0109] In one embodiment of the present specification, R11 to R18 are identical or different from one another and are each independently hydrogen; deuterium; a substituted or unsubstituted alkyl group; a substituted or unsubstituted cycloalkyl group; a substituted or unsubstituted silyl group; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heteroaryl group.

[0110] In one embodiment of the present specification, R11 to R18 are identical or different from one another and are each independently hydrogen; deuterium; a substituted or unsubstituted C1-C10 alkyl group; a substituted or unsubstituted C3-C10 cycloalkyl group; a substituted or unsubstituted C1-C60 silyl group; a substituted or unsubstituted C6-C30 aryl group; or a substituted or unsubstituted C2-C30 heteroaryl group.

[0111] In one embodiment of the present specification, R11 to R18 are identical or different from one another and are each independently hydrogen; deuterium; a substituted or unsubstituted C1-C8 alkyl group; a substituted or unsubstituted C3-C6 cycloalkyl group; a substituted or unsubstituted C1-C40 silyl group; a substituted or unsubstituted C6-C20 aryl group; or a substituted or unsubstituted C2-C20 heteroaryl group.

[0112] In one embodiment of the present specification, R11 to R18 are identical or different from one another and are each independently hydrogen; deuterium; methyl group; ethyl group; propyl group; isopropyl group; butyl group; tert-butyl group; octyl group; phenyl group; biphenyl group; terphenyl group; naphthyl group; fluorenyl group; anthracenyl group; phenanthrenyl group; carbazole group; dibenzofuran group; dibenzothiophen group; quinoline group; pyridine group; pyrimidine group; or triazine group. In another embodiment, the substituent is substituted or unsubstituted with a C1-C6 alkyl group; a substituted or unsubstituted C6-C20 aryl group; or a substituted or unsubstituted C2-C20 heteroaryl group.

[0113] In one embodiment of the present specification, R11 to R18 are identical or different from one another and are each independently hydrogen; deuterium; octyl group; or phenyl group.

[0114] In one embodiment of the present specification, R11, R14, R15, and R18 are identical or different from one another and each independently combine with an adjacent Ar101 or Ar102 to form a substituted or unsubstituted ring.

[0115] In one embodiment of the present specification, R11 combines with Ar101 to form a substituted or unsubstituted ring.

[0116] In one embodiment of the present specification, R14 combines with Ar102 to form a substituted or unsubstituted ring.

[0117] In one embodiment of the present specification, R15 combines with Ar102 to form a substituted or unsubstituted ring.

[0118] In one embodiment of the present specification, the R18 combines with Ar101 to form a substituted or unsubstituted ring.

[0119] In one embodiment of the present specification, R11 is combined with Ar101 to form a pentagonal ring.

[0120] In one embodiment of the present specification, the R14 is combined with Ar102 to form a pentagonal ring.

[0121] In one embodiment of the present specification, R15 is combined with Ar102 to form a pentagonal ring.

[0122] In one embodiment of the present specification, the R18 is combined with Ar101 to form a pentagonal ring.

[0123] In one embodiment of the present specification, at least one of R12, R13, R16 and R17 is a C1-C10 alkyl group; or a C6-C20 aryl group, and the remainder is hydrogen; or deuterium.

[0124] In one embodiment of the present specification, at least one of R12, R13, R16 and R17 is an octyl group; or a phenyl group, and the remainder is hydrogen; or deuterium.

[0125] In one embodiment of the present specification, at least 4 of the R11 to R18 are deuterium.

[0126] In one embodiment of the present specification, R11 to R18 are each deuterium.

[0127] In one embodiment of the present specification, at least one of R11 to R18 is deuterium, and the remainder is hydrogen.

[0128] In one embodiment of the present specification, at least four of R11 to R18 are deuterium, and the remainder is hydrogen.

[0129] In one embodiment of the present specification, R12 is an octyl group; or a phenyl group.

[0130] In one embodiment of the present specification, R13 is an octyl group; or a phenyl group.

[0131] In one embodiment of the present specification, R16 is an octyl group; or a phenyl group.

[0132] In one embodiment of the present specification, R17 is an octyl group; or a phenyl group.

[0133] In one embodiment of the present specification, the R11 is dehydrogenated by 40% or more; 50% or more; 60% or more; 70% or more; 80% or more; 90% or more; or 100%.

[0134] In one embodiment of the present specification, the R12 is dehydrogenated by 40% or more; 50% or more; 60% or more; 70% or more; 80% or more; 90% or more; or 100%.

[0135] In one embodiment of the present specification, the R13 is dehydrogenated by 40% or more; 50% or more; 60% or more; 70% or more; 80% or more; 90% or more; or 100%.

[0136] In one embodiment of the present specification, the R14 is dehydrogenated by 40% or more; 50% or more; 60% or more; 70% or more; 80% or more; 90% or more; or 100%.

[0137] In one embodiment of the present specification, the R15 is dehydrogenated by 40% or more; 50% or more; 60% or more; 70% or more; 80% or more; 90% or more; or 100%.

[0138] In one embodiment of the present specification, the R16 is dehydrogenated by 40% or more; 50% or more; 60% or more; 70% or more; 80% or more; 90% or more; or 100%.

[0139] In one embodiment of the present specification, the R17 is dehydrogenated by 40% or more; 50% or more; 60% or more; 70% or more; 80% or more; 90% or more; or 100%.

[0140] In one embodiment of the present specification, the R18 is dehydrogenated by 40% or more; 50% or more; 60% or more; 70% or more; 80% or more; 90% or more; or 100%.

[0141] In one embodiment of the present specification, Ar101 and Ar102 are identical or different from each other and are each independently substituted or unsubstituted aryl groups; or substituted or unsubstituted heteroaryl groups, or adjacent substituents are combined to form a substituted or unsubstituted ring.

[0142] In one embodiment of the present specification, Ar101 and Ar102 are identical or different from each other and are each independently substituted or unsubstituted C6-C50 aryl groups; or substituted or unsubstituted C2-C50 heteroaryl groups, or adjacent substituents are combined to form a substituted or unsubstituted C2-C50 ring.

[0143] In one embodiment of the present specification, Ar101 and Ar102 are identical or different from each other and are each independently substituted or unsubstituted C6-C30 aryl groups; or substituted or unsubstituted C2-C30 heteroaryl groups, or adjacent substituents are combined to form a substituted or unsubstituted C2-C30 ring.

[0144] In one embodiment of the present specification, Ar101 and Ar102 are identical or different from each other and are each independently substituted or unsubstituted C6-C20 aryl groups; or substituted or unsubstituted C2-C20 heteroaryl groups, or adjacent substituents are combined to form a substituted or unsubstituted C2-C20 ring. The aryl group, heteroaryl group, or ring is substituted or unsubstituted with a C1-C10 alkyl group or a C6-C20 aryl group.

[0145] In one embodiment of the present specification, Ar101 and Ar102 are identical or different from each other and are each independently a C6-C30 aryl group substituted or unsubstituted with a C1-C10 alkyl group; or a C2-C30 heteroaryl group substituted or unsubstituted with a C6-C20 aryl group, or form a C2-C30 ring with adjacent R11, R14, R15 or R18.

[0146] In one embodiment of the present specification, Ar101 and Ar102 are identical or different from each other and are each independently substituted or unsubstituted C6-C20 aryl groups; or substituted or unsubstituted C2-C20 heteroaryl groups.

[0147] In one embodiment of the present specification, Ar101 and Ar102 are identical or different from each other and are each independently a C6-C30 aryl group substituted or unsubstituted with a C1-C10 alkyl group; or a C2-C30 heteroaryl group substituted or unsubstituted with a C6-C20 aryl group.

[0148] In one embodiment of the present specification, at least one of Ar101 and Ar102 is a substituted or unsubstituted heteroaryl group.

[0149] In one embodiment of the present specification, one of Ar101 and Ar102 is a substituted or unsubstituted heteroaryl group, and the other is a substituted or unsubstituted aryl group.

[0150] In one embodiment of the present specification, at least one of Ar101 and Ar102 is a substituted or unsubstituted O-containing heteroaryl group; or a substituted or unsubstituted S-containing heteroaryl group.

[0151] In one embodiment of the present specification, one of Ar101 and Ar102 is a substituted or unsubstituted O-containing heteroaryl group; or a substituted or unsubstituted S-containing heteroaryl group, and the other is a substituted or unsubstituted aryl group.

[0152] In one embodiment of the present specification, one of Ar101 and Ar102 is an O-containing heteroaryl group substituted or unsubstituted with an aryl group; or an S-containing heteroaryl group substituted or unsubstituted with an aryl group, and the other is a substituted or unsubstituted aryl group.

[0153] In one embodiment of the present specification, one of Ar101 and Ar102 is a substituted or unsubstituted C2-C20 heteroaryl group, and the other is a substituted or unsubstituted C6-C20 aryl group.

[0154] In one embodiment of the present specification, one of Ar101 and Ar102 is an O-containing C2-C20 heteroaryl group substituted or unsubstituted with a C6-C30 aryl group; or an S-containing C2-C20 heteroaryl group substituted or unsubstituted with a C6-C30 aryl group, and the other is a C6-C20 aryl group.

[0155] When the above chemical formula 1 contains a heteroaryl group as Ar1 or Ar2, the long lifespan characteristics of the device are improved compared to when both Ar1 and Ar2 are aryl groups.

[0156] In one embodiment of the present specification, Ar101 and Ar102 are identical or different from each other and each independently comprises a substituted or unsubstituted phenyl group; a substituted or unsubstituted biphenyl group; a substituted or unsubstituted terphenyl group; a substituted or unsubstituted naphthyl group; a substituted or unsubstituted fluorenyl group; a substituted or unsubstituted anthracenyl group; a substituted or unsubstituted phenanthrenyl group; a substituted or unsubstituted fluoranthenyl group; a substituted or unsubstituted carbazole group; a substituted or unsubstituted dibenzofuran group; a substituted or unsubstituted dibenzothiophen group; a substituted or unsubstituted naphthobenzofuran group; a substituted or unsubstituted naphthobenzothiophen group; a substituted or unsubstituted benzocarbazole group; a substituted or unsubstituted indole group; a substituted or unsubstituted furan group; a substituted or unsubstituted thiophene group; a substituted or unsubstituted quinoline group; a substituted or unsubstituted pyridine group; It is a substituted or unsubstituted pyrimidine group; or a substituted or unsubstituted triazine group.

[0157] In one embodiment of the present specification, Ar101 and Ar102 are identical or different from each other and are each independently a substituted or unsubstituted phenyl group; a substituted or unsubstituted biphenyl group; a substituted or unsubstituted naphthyl group; a substituted or unsubstituted phenanthrenyl group; a substituted or unsubstituted fluoranthenyl group; a substituted or unsubstituted dibenzofuran group; a substituted or unsubstituted dibenzothiophen group; a substituted or unsubstituted naphthobenzofuran group; a substituted or unsubstituted quinoline group; or a substituted or unsubstituted pyridine group.

[0158] In one embodiment of the present specification, Ar101 and Ar102 are identical or different from each other and are each independently a phenyl group; a biphenyl group; a naphthyl group; a phenanthrenyl group; a fluoranthenyl group; a dibenzofuran group; a dibenzothiophen group; a naphthobenzofuran group; a quinoline group; or a pyridine group.

[0159] In one embodiment of the present specification, at least one of Ar101 and Ar102 is a substituted or unsubstituted dibenzofuran group; a substituted or unsubstituted dibenzothiophen group; a substituted or unsubstituted naphthobenzofuran group; a substituted or unsubstituted quinoline group; or a substituted or unsubstituted pyridine group.

[0160] In one embodiment of the present specification, at least one of Ar101 and Ar102 is a substituted or unsubstituted dibenzofuran group; a substituted or unsubstituted dibenzothiophen group; or a substituted or unsubstituted naphthobenzofuran group.

[0161] In one embodiment of the present specification, one of Ar101 and Ar102 is a dibenzofuran group; a dibenzothiophen group; a naphthobenzofuran group; a quinoline group; or a pyridine group, and the other is a phenyl group; a biphenyl group; a naphthyl group; a phenanthrenyl group; or a fluoranthenyl group.

[0162] In one embodiment of the present specification, the Ar101 combines with R11 to form a substituted or unsubstituted ring.

[0163] In one embodiment of the present specification, the Ar101 combines with R18 to form a substituted or unsubstituted ring.

[0164] In one embodiment of the present specification, the Ar102 combines with R14 to form a substituted or unsubstituted ring.

[0165] In one embodiment of the present specification, the Ar102 combines with R15 to form a substituted or unsubstituted ring.

[0166] In one embodiment of the present specification, the Ar101 is combined with R11 to form a pentagonal ring.

[0167] In one embodiment of the present specification, the Ar101 is combined with R18 to form a pentagonal ring.

[0168] In one embodiment of the present specification, the Ar102 is combined with R14 to form a pentagonal ring.

[0169] In one embodiment of the present specification, the Ar102 is combined with R15 to form a pentagonal ring.

[0170] In one embodiment of the present specification, the Ar101 is dehydrogenated by 40% or more; 50% or more; 60% or more; 70% or more; 80% or more; 90% or more; or 100%.

[0171] In one embodiment of the present specification, the Ar102 is dehydrogenated by 40% or more; 50% or more; 60% or more; 70% or more; 80% or more; 90% or more; or 100%.

[0172] In one embodiment of the present specification, m1 and m2 are integers from 0 to 5, and when m1 is 2 or more, L101 are the same or different from each other, and when m2 is 2 or more, L102 are the same or different from each other.

[0173] In one embodiment of the present specification, m1 is 0, 1, or 2.

[0174] In one embodiment of the present specification, m2 is 0, 1, or 2.

[0175] In one embodiment of the present specification, m1 is 0 or 1.

[0176] In one embodiment of the present specification, m2 is 0 or 1.

[0177] In one embodiment of the present specification, -(L101) of Formula 1 m1 -Ar101 and -(L102) m2 -Ar102 are different from each other.

[0178] In one embodiment of the present specification, the compound represented by the chemical formula 1 is any one selected from the following compounds M1 to M34.

[0179] [Compound M1]

[0180]

[0181] (In compound M1, the value of x + y + z + n is 20 to 26.)

[0182] [Compound M2]

[0183]

[0184] (In compound M2, the value of x + y + z + p + n is 24 to 30.)

[0185] [Compound M3]

[0187]

[0188] (In compound M3, the value of x + y + z + p + n + r is 26 to 32.)

[0189] [Compound M4]

[0190]

[0191] (In compound M4, the value of x + y + z + q + n is 22 to 30.)

[0192] [Compound M5]

[0193]

[0194] (In compound M5, the value of x + y + z + p + n + q is 28 to 34.)

[0195] [Compound M6]

[0196]

[0197] (In compound M6, the value of x + y + z + n is 14 to 18.)

[0198] [Compound M7]

[0199]

[0200] (In compound M7, the value of x + y + z + p + n is 22 to 28.)

[0201] [Compound M8]

[0202]

[0203] (In compound M8, the value of x + y + z is 16 to 22.)

[0204] [Compound M9]

[0205]

[0206] (In compound M9, the value of x + y + z + n is 20 to 26.)

[0207] [Compound M10]

[0208]

[0209] (In compound M10, the value of x + y + z + p + n is 22 to 28.)

[0210] [Compound M11]

[0211]

[0212] (In compound M11, the value of x + y + z + n is 20 to 26.)

[0213] [Compound M12]

[0214]

[0215] (In compound M12, the value of x + y + z is 18 to 24.)

[0216] [Compound M13]

[0217]

[0218] (In compound M13, the value of x + y + z + p + n is 21 to 27.)

[0219] [Compound M14]

[0220]

[0221] (In compound M14, the value of x + y + z + n is 16 to 22.)

[0222] [Compound M15]

[0223]

[0224] (In compound M15, the value of x + y + z + n is 20 to 26.)

[0226] [Compound M16]

[0227]

[0228] (In compound M16, the value of x + y + z + p is 14 to 20.)

[0229] [Compound M17]

[0230]

[0231] (In compound M17, the value of x + y + z + p is 19 to 25.)

[0232] [Compound M18]

[0233]

[0234] (In compound M18, the value of x + y + z + n is 19 to 25.)

[0235] [Compound M19]

[0236]

[0237] (In compound M19, the value of x + y + z + p + n is 20 to 26.)

[0238] [Compound M20]

[0239]

[0240] (In compound M20, the value of x + y + z is 14 to 20.)

[0241] [Compound M21]

[0242]

[0243] (In compound M21, the value of x + y + z is 14 to 20.)

[0244] [Compound M22]

[0245]

[0246] (In compound M22, the value of x + y + z is 14 to 20.)

[0247] [Compound M23]

[0248]

[0249] (In compound M23, the value of x + y + z is 14 to 20.)

[0250] [Compound M24]

[0251]

[0252] (In compound M24, the value of x + y + z + n is 18 to 24.)

[0253] [Compound M25]

[0254]

[0255] (In compound M25, the value of x + y + z + p is 16 to 22.)

[0256] [Compound M26]

[0257]

[0258] (In compound M26, the value of x + y + z + n is 12 to 24.)

[0259] [Compound M27]

[0260]

[0261] (In compound M27, the value of x + y + z + n is 13 to 26.)

[0262] [Compound M28]

[0263]

[0264] (In compound M28, the value of x + y + z + n is 16 to 22.)

[0265] [Compound M29]

[0266]

[0267] (In compound M29, the value of x + y + z + n is 12 to 24.)

[0268] [Compound M30]

[0269]

[0270] (In compound M30, the value of x + y + z is 12 to 24.)

[0271] [Compound M31]

[0272]

[0273] (In compound M31, the value of x + y + z is 11 to 22.)

[0274] [Compound M32]

[0275]

[0276] (In compound M32, the value of x + y + z is 11 to 22.)

[0277] [Compound M33]

[0278]

[0279] (In compound M33, the value of x + y + z + p + n is 15 to 30.)

[0280] [Compound M34]

[0281]

[0282] (In compound M34, the value of x + y + z is 11 to 22.)

[0283] In the above compounds M1 to M34, x to z, n and p represent the number of substituted deuterium atoms. In one embodiment, compounds M1 to M34 are each deuterided by at least 40%. In one embodiment, compounds M1 to M34 are each deuterided by at least 50%. In one embodiment, compounds M1 to M34 are each deuterided by at least 60%. In one embodiment, compounds M1 to M34 are each deuterided by at least 70%. In one embodiment, compounds M1 to M34 are each deuterided by at least 80%. In one embodiment, compounds M1 to M34 are each deuterided by at least 90%. In one embodiment, compounds M1 to M34 are each deuterided by at least 100%.

[0284] In one embodiment of the present specification, the compound represented by Chemical Formula 1 is any one selected from the following compounds.

[0285]

[0286]

[0287]

[0288]

[0289]

[0290]

[0291]

[0292]

[0293]

[0294]

[0295]

[0296]

[0297]

[0298]

[0299]

[0300]

[0301]

[0302]

[0303]

[0304]

[0305]

[0306]

[0307]

[0308]

[0309]

[0310]

[0311]

[0312]

[0313]

[0314]

[0315]

[0316]

[0317]

[0318]

[0319]

[0320]

[0321]

[0322]

[0323]

[0324]

[0325]

[0326]

[0327]

[0328]

[0329]

[0330]

[0331]

[0332]

[0333]

[0334] In one embodiment of the present specification, Y is O; or S.

[0335] In one embodiment of the present specification, Y is O.

[0336] In one embodiment of the present specification, Y is S.

[0337] In one embodiment of the present specification, R21 to R24 are identical or different from each other and are each independently hydrogen; deuterium; nitrile group; substituted or unsubstituted alkyl group; substituted or unsubstituted aryl group; or substituted or unsubstituted heterocyclic group, represented by Formula 3, or adjacent substituents are combined to form a substituted or unsubstituted ring, and at least one of R21 to R24 is represented by Formula 3.

[0338] In one embodiment of the present specification, the R21 is represented by the chemical formula 3.

[0339] In one embodiment of the present specification, the R22 is represented by the chemical formula 3.

[0340] In one embodiment of the present specification, the R23 is represented by the chemical formula 3.

[0341] In one embodiment of the present specification, the R24 is represented by the chemical formula 3.

[0342] In one embodiment of the present specification, R21 to R24 are identical or different from each other and are each independently hydrogen; deuterium; nitrile group; a substituted or unsubstituted C1-C10 alkyl group; a substituted or unsubstituted C6-C30 aryl group; or a substituted or unsubstituted C6-C30 heterocyclic group, represented by Formula 3, or adjacent substituents are combined to form a substituted or unsubstituted C3-C30 ring.

[0343] In one embodiment of the present specification, R21 to R24 are identical or different from each other and are each independently hydrogen; deuterium; a nitrile group; a C1-C10 alkyl group; or a C6-C30 aryl group substituted or unsubstituted with a nitrile group or a C1-C10 alkyl group, represented by Formula 3, or adjacent substituents are combined to form a benzene ring.

[0344] In one embodiment of the present specification, R21 to R24 are identical or different from each other and are each independently hydrogen; deuterium; nitrile group; methyl group; ethyl group; propyl group; isopropyl group; n-butyl group; sec-butyl group; tert-butyl group; phenyl group substituted or unsubstituted with nitrile group, methyl group or tert-butyl group; biphenyl group; or naphthyl group, represented by the above formula 3, or adjacent substituents are bonded to each other to form a benzene ring.

[0345] In one embodiment of the present specification, one or more of R21 to R24 are represented by the formula 3, and the remainders are identical or different from one another and are each independently hydrogen; deuterium; a nitrile group; a substituted or unsubstituted C1-C10 alkyl group; or a substituted or unsubstituted C6-C30 aryl group, or two adjacent R21s, two adjacent R22s, two adjacent R23s, or two adjacent R24s are combined with each other to form a substituted or unsubstituted C3-C30 ring.

[0346] In one embodiment of the present specification, one or two of the R21 to R24 are represented by the formula 3, and the remainders are identical or different from one another, each independently hydrogen; deuterium; a nitrile group; a C1-C10 alkyl group; or a C6-C30 aryl group substituted or unsubstituted with a nitrile group, or two of adjacent R21s or two of adjacent R22s are combined with each other to form a benzene ring.

[0347] In one embodiment of the present specification, one or two of R21 to R24 are represented by the formula 3, and the remainders are identical or different from one another, and each independently hydrogen; deuterium; nitrile group; methyl group; ethyl group; propyl group; isopropyl group; n-butyl group; sec-butyl group; tert-butyl group; phenyl group substituted or unsubstituted with a nitrile group, methyl group or tert-butyl group; biphenyl group; or naphthyl group, or adjacent substituents are bonded to each other to form a benzene ring.

[0348] In one embodiment of the present specification, one or two of the R21 to R24 are represented by the formula 3, and the remainders are identical or different from one another, and each independently hydrogen; deuterium; nitrile group; methyl group; butyl group; phenyl group substituted or unsubstituted with a nitrile group; biphenyl group substituted or unsubstituted with a nitrile group; or naphthyl group, or two adjacent R21s or two adjacent R22s are combined with each other to form a benzene ring.

[0349] In one embodiment of the present specification, the R21s combine with each other to form a substituted or unsubstituted benzene ring.

[0350] In one embodiment of the present specification, the R22s combine with each other to form a substituted or unsubstituted benzene ring.

[0351] In one embodiment of the present specification, the R21s combine with each other to form a benzene ring.

[0352] In one embodiment of the present specification, the R22s combine with each other to form a benzene ring.

[0353] In one embodiment of the present specification, r21 to r24 are identical or different from each other and are each independently integers from 0 to 4, and if r21 is 2 or more, R21 is identical or different from each other, if r22 is 2 or more, R22 is identical or different from each other, if r23 is 2 or more, R23 is identical or different from each other, and if r24 is 2 or more, R24 is identical or different from each other.

[0354] In one embodiment of the present specification, r21 to r24 are identical or different from each other and are each independently 0 to 2.

[0355] In one embodiment of the present specification, X1 is N or C(R31).

[0356] In one embodiment of the present specification, X2 is N or C(R32).

[0357] In one embodiment of the present specification, X3 is N or C(R33).

[0358] In one embodiment of the present specification, one or more of X1 to X3 are N.

[0359] In one embodiment of the present specification, at least two of X1 to X3 are N.

[0360] In one embodiment of the present specification, X1 to X3 are all N.

[0361] In one embodiment of the present specification, X1 is N, X2 is N, and X3 is C(R33). In another embodiment, R33 combines with Ar2 to form a benzene ring.

[0362] In one embodiment of the present specification, X1 is N, X2 is C(R32), and X3 is N. In another embodiment, R33 combines with Ar2 to form a benzene ring.

[0363] In one embodiment of the present specification, R31, R32, and R33 are identical or different from one another and each independently hydrogen; deuterium; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heterocyclic group, or combine with Ar1 or Ar2 to form a substituted or unsubstituted aromatic hydrocarbon ring; or a substituted or unsubstituted heterocyclic group.

[0364] In one embodiment of the present specification, R31, R32, and R33 are identical or different from one another and each independently are hydrogen; deuterium; a substituted or unsubstituted C6-C30 aryl group; or a substituted or unsubstituted C2-C30 heterocyclic group, or combine with Ar1 or Ar2 to form a substituted or unsubstituted C6-C30 aromatic hydrocarbon ring; or a substituted or unsubstituted C2-C30 heterocyclic group. In another embodiment, “substituted or unsubstituted” means substituted with a substituent selected from the group consisting of deuterium, a C1-C10 alkyl group, a C6-C30 aryl group, and a C2-C30 heteroaryl group, or a substituent formed by connecting two or more substituents, or having no substituents.

[0365] In one embodiment of the present specification, R31, R32, and R33 are identical or different from one another and each independently are hydrogen; deuterium; a substituted or unsubstituted single- to four-ring aryl group; or a substituted or unsubstituted single- to four-ring heterocyclic group, or combine with Ar1 or Ar2 to form a substituted or unsubstituted single- to four-ring aromatic hydrocarbon ring; or a substituted or unsubstituted single- to four-ring heterocyclic group. In another embodiment, “substituted or unsubstituted” means substituted with a substituent selected from the group consisting of deuterium, a C1-C10 alkyl group, a C6-C30 aryl group, and a C2-C30 heteroaryl group, or a substituent formed by connecting two or more substituents, or having no substituents.

[0366] In one embodiment of the present specification, R31, R32 and R33 are identical or different from each other and each independently is hydrogen; deuterium; phenyl group; biphenyl group; naphthyl group; carbazole group; phenylcarbazole group; or benzocarbazole group, or combines with Ar1 or Ar2 to form a benzene ring substituted or unsubstituted with a C6-C30 aryl group or a C2-C30 heterocyclic group.

[0367] In one embodiment of the present specification, R31, R32, and R33 are each hydrogen or deuterium.

[0368] In one embodiment of the present specification, R31, R32 and R33 are hydrogen.

[0369] In one embodiment of the present specification, R31 combines with Ar1 to form a substituted or unsubstituted ring; a substituted or unsubstituted hydrocarbon ring; or a substituted or unsubstituted heteroring.

[0370] In one embodiment of the present specification, the R32 combines with Ar1 to form a substituted or unsubstituted ring; a substituted or unsubstituted hydrocarbon ring; or a substituted or unsubstituted heteroring.

[0371] In one embodiment of the present specification, the R32 combines with Ar2 to form a substituted or unsubstituted ring; a substituted or unsubstituted hydrocarbon ring; or a substituted or unsubstituted heteroring.

[0372] In one embodiment of the present specification, the R33 combines with Ar2 to form a substituted or unsubstituted ring; a substituted or unsubstituted hydrocarbon ring; or a substituted or unsubstituted heteroring.

[0373] In one embodiment of the present specification, R31 combines with Ar1 to form a benzene ring substituted or unsubstituted with R41.

[0374] In one embodiment of the present specification, R32 combines with Ar1 to form a benzene ring substituted or unsubstituted with R41.

[0375] In one embodiment of the present specification, R32 combines with Ar2 to form a benzene ring substituted or unsubstituted with R41.

[0376] In one embodiment of the present specification, R33 combines with Ar2 to form a benzene ring substituted or unsubstituted with R41.

[0377] In one embodiment of the present specification, Ar1 and Ar2 are identical or different from each other and are each independently substituted or unsubstituted aryl groups; or substituted or unsubstituted heterocyclic groups, or formed by combining with R31, R32 or R33 to form substituted or unsubstituted aromatic hydrocarbon rings; or substituted or unsubstituted heterocyclic groups.

[0378] In one embodiment of the present specification, Ar1 and Ar2 are identical or different from each other and are each independently one selected from the group consisting of deuterium, nitrile group, C1-C10 alkyl group, C1-C10 alkoxy group substituted or unsubstituted with a halogen group, C6-C30 aryl group, and C2-C20 heterocyclic group, or a C6-C30 aryl group substituted or unsubstituted with a substituent connected to two or more substituents selected from said group; or one selected from the group consisting of deuterium, nitrile group, C1-C10 alkyl group, C1-C10 alkoxy group substituted or unsubstituted with a halogen group, C6-C30 aryl group, and C2-C20 heterocyclic group, or a C6-C30 heterocyclic group substituted or unsubstituted with a substituent connected to two or more substituents selected from said group.

[0379] In one embodiment of the present specification, Ar1 and Ar2 are identical or different from each other and are each independently a C6-C30 aryl group substituted or unsubstituted with one selected from the group consisting of a deuterium, a nitrile group, a C1-C10 alkyl group, a C1-C10 alkoxy group substituted or unsubstituted with a halogen group, a C6-C30 aryl group, and a C2-C20 heterocyclic group, or a C6-C30 heterocyclic group substituted or unsubstituted with a substituent connected to two or more substituents selected from said group; or a C6-C30 heterocyclic group.

[0380] In one embodiment of the present specification, Ar1 and Ar2 are identical or different from each other and are each independently a C6-C30 aryl group substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium, nitrile group, C1-C10 alkyl group, C1-C10 alkoxy group substituted or unsubstituted with a halogen group, C6-C30 aryl group, and C2-C20 heterocyclic group, or a substituent connected with two or more substituents selected from said group.

[0381] In one embodiment of the present specification, Ar1 and Ar2 are identical or different from each other and each independently substituted or unsubstituted with a substituent connected to one or more groups selected from the group consisting of deuterium, nitrile group, methyl group, trifluoromethoxy group, phenyl group, naphthyl group, dimethylfluorene group, phenanthrenyl group, phenalene group, fluoranthenyl group, pyridine group, quinoline group, carbazole group, benzocarbazole group, dibenzofuran group, and dibenzothiophen group, or two or more groups selected from said group; Or it is a C2-C20 heterocyclic group substituted or unsubstituted with a substituent connected to one or more groups selected from the group consisting of deuterium, nitrile group, methyl group, trifluoromethoxy group, phenyl group, naphthyl group, dimethylfluorene group, phenanthrenyl group, phenalene group, fluoranthenyl group, pyridine group, quinoline group, carbazole group, benzocarbazole group, dibenzofuran group and dibenzothiophen group, or two or more groups selected from said group.

[0382] In one embodiment of the present specification, Ar1 and Ar2 are identical or different from each other and are each independently C6-C20 aryl groups substituted or unsubstituted with a substituent connected to one or more groups selected from the group consisting of deuterium, nitrile group, methyl group, trifluoromethoxy group, phenyl group, naphthyl group, dimethylfluorene group, phenanthrenyl group, phenalene group, fluoranthenyl group, pyridine group, quinoline group, carbazole group, benzocarbazole group, dibenzofuran group and dibenzothiophen group, or two or more groups selected from said group.

[0383] In one embodiment of the present specification, Ar1 and Ar2 are identical or different from each other and are each independently an aryl group substituted or unsubstituted with R41; or a heterocyclic group substituted or unsubstituted with R42, or an aromatic hydrocarbon ring substituted or unsubstituted with R41 by combining with R31, R32 or R33; or a heterocyclic group substituted or unsubstituted with R42.

[0384] In one embodiment of the present specification, Ar1 and Ar2 are identical or different from each other and are each independently an aryl group of C6-C30 substituted or unsubstituted with R41; or a heterocyclic group of C2-C30 substituted or unsubstituted with R42, or an aromatic hydrocarbon ring of C6-C30 substituted or unsubstituted with R41 by combining with R31, R32 or R33; or a heterocyclic group of C2-C30 substituted or unsubstituted with R42.

[0385] In one embodiment of the present specification, Ar1 and Ar2 are identical or different from each other and are each independently an aryl group of C6-C20 substituted or unsubstituted with R41; or a heterocyclic group of C2-C20 substituted or unsubstituted with R42, or an aromatic hydrocarbon ring of C6-C20 substituted or unsubstituted with R41 by combining with R31, R32 or R33; or a heterocyclic group of C2-C20 substituted or unsubstituted with R42.

[0386] In one embodiment of the present specification, Ar1 and Ar2 are identical or different from each other and are each independently an aryl group of one to five rings substituted or unsubstituted with R41; or a heterocyclic group of one to five rings substituted or unsubstituted with R42, or a single to five ring aromatic hydrocarbon ring substituted or unsubstituted with R41 by combining with R31, R32 or R33; or a heterocyclic group of one to five rings substituted or unsubstituted with R42.

[0387] In one embodiment of the present specification, Ar1 and Ar2 are identical or different from each other and are each independently a single-ring to four-ring aryl group substituted or unsubstituted with R41; or a single-ring to four-ring heterocyclic group substituted or unsubstituted with R42, or a single-ring to four-ring aromatic hydrocarbon ring substituted or unsubstituted with R41 by combining with R31, R32 or R33; or a single-ring to four-ring heterocyclic group substituted or unsubstituted with R42.

[0388] In one embodiment of the present specification, Ar1 and Ar2 are identical or different from each other and are each independently a single to three-ring aryl group substituted or unsubstituted with R41; or a single to three-ring heterocyclic group substituted or unsubstituted with R42, or a single to three-ring aromatic hydrocarbon ring substituted or unsubstituted with R41 by combining with R31, R32 or R33; or a single to three-ring heterocyclic group substituted or unsubstituted with R42.

[0389] In one embodiment of the present specification, Ar1 and Ar2 are identical or different from each other and are each independently a phenyl group; a biphenyl group; a terphenyl group; a naphthyl group; a phenanthrenyl group; a triphenylene group; a fluoranthenyl group; a phenalene group; anthracenyl group; a fluorenyl group; or a dimethylfluorenyl group, and the substituent is substituted or unsubstituted with R41.

[0390] In one embodiment of the present specification, Ar1 and Ar2 are identical or different from each other, and are each independently substituted or unsubstituted with R42 and are single to five-ring heterocyclic rings containing N, O, S or Si.

[0391] In one embodiment of the present specification, Ar1 and Ar2 are identical or different from each other and are each independently a carbazole group; a phenylcarbazole group; a benzocarbazole group; an indenocarbazole group; a dibenzothiophen group; a dibenzofuran group; a dibenzosilole group; a phenoxazine group; a phenothiazine group; aphenazine group; an acridine group; a dihydrophenazine group; a dihydroacridine group; a pyridyl group; a pyrimidyl group; a quinoline group; an isoquinoline group; a quinazolin group; a pyridopyrimidine group; a pyridopyrizine group; a pyrimidoindole group; or a pyridodole group, and the substituent is substituted or unsubstituted with R42.

[0392] In one embodiment of the present specification, Ar1 combines with R31 to form a substituted or unsubstituted ring; a substituted or unsubstituted hydrocarbon ring; or a substituted or unsubstituted heteroring.

[0393] In one embodiment of the present specification, Ar1 combines with R32 to form a substituted or unsubstituted ring; a substituted or unsubstituted hydrocarbon ring; or a substituted or unsubstituted heteroring.

[0394] In one embodiment of the present specification, the Ar2 combines with R32 to form a substituted or unsubstituted ring; a substituted or unsubstituted hydrocarbon ring; or a substituted or unsubstituted heteroring.

[0395] In one embodiment of the present specification, the Ar2 combines with R33 to form a substituted or unsubstituted ring; a substituted or unsubstituted hydrocarbon ring; or a substituted or unsubstituted heteroring.

[0396] In one embodiment of the present specification, Ar1 combines with R31 to form a benzene ring substituted or unsubstituted with R41.

[0397] In one embodiment of the present specification, Ar1 combines with R32 to form a benzene ring substituted or unsubstituted with R41.

[0398] In one embodiment of the present specification, the Ar2 combines with R32 to form a benzene ring substituted or unsubstituted with R41.

[0399] In one embodiment of the present specification, the Ar2 combines with R33 to form a benzene ring substituted or unsubstituted with R41.

[0400] In one embodiment of the present specification, R41 and R42 are identical or different from each other and are each independently selected from the group consisting of deuterium; halogen group; nitrile group; alkyl group; haloalkyl group; alkoxy group; silyl group; aryl group; and heterocyclic group, or have two or more substituents connected thereto.

[0401] In one embodiment of the present specification, R41 and R42 are identical or different from each other and are each independently selected from the group consisting of deuterium; halogen group; nitrile group; C1-C20 alkyl group; C1-C20 haloalkyl group; C1-C20 alkoxy group; C1-C50 silyl group; C6-C50 aryl group; and C2-C50 heterocyclic group, or have two or more substituents connected thereto.

[0403] In one embodiment of the present specification, R41 and R42 are identical or different from each other and are each independently selected from the group consisting of deuterium; halogen group; nitrile group; C1-C10 alkyl group; C1-C10 haloalkyl group; C1-C10 alkoxy group; C1-C30 silyl group; C6-C30 aryl group; and C2-C30 heterocyclic group, or have two or more substituents connected thereto.

[0404] In one embodiment of the present specification, R41 and R42 are identical or different from each other and are each independently selected from the group consisting of deuterium; halogen group; nitrile group; C1-C5 alkyl group; C1-C5 haloalkyl group; C1-C5 alkoxy group; C1-C20 silyl group; C6-C20 aryl group; and C2-C20 heterocyclic group, or have two or more substituents connected thereto.

[0405] In one embodiment of the present specification, R41 and R42 are identical or different from each other and are each independently selected from the group consisting of deuterium; halogen group; nitrile group; C1-C20 alkyl group; C1-C20 haloalkyl group; C1-C20 alkoxy group; C1-C50 silyl group; a single- to five-ring aryl group; and a single- to five-ring heterocyclic group, or have two or more substituents connected thereto.

[0406] In one embodiment of the present specification, R41 and R42 are identical or different from each other and are each independently selected from the group consisting of deuterium; halogen group; nitrile group; C1-C10 alkyl group; C1-C10 haloalkyl group; C1-C10 alkoxy group; C1-C30 silyl group; a single- to four-ring aryl group; and a single- to four-ring heterocyclic group, or have two or more substituents connected thereto.

[0407] In one embodiment of the present specification, R41 and R42 are identical or different from each other and are each independently selected from the group consisting of deuterium; halogen group; nitrile group; C1-C5 alkyl group; C1-C5 haloalkyl group; C1-C5 alkoxy group; C1-C20 silyl group; a single to three-ring aryl group; and a single to three-ring heterocyclic group, or have two or more substituents connected thereto.

[0408] In one embodiment of the present specification, R41 and R42 are identical or different from each other and each independently deuterium; nitrile group; methyl group; ethyl group; propyl group; isopropyl group; n-butyl group; tert-butyl group; trifluoromethyl group; methoxy group; ethoxy group; trimethylsilyl group; triphenylsilyl group; phenyl group; biphenyl group; terphenyl group; naphthyl group; phenanthrenyl group; triphenylene group; fluoranthenyl group; phenalene group; anthracenyl group; fluorenyl group; dimethylfluorenyl group; carbazole group; phenylcarbazole group; benzocarbazole group; indenocarbazole group; dibenzothiophen group; dibenzofuran group; dibenzosilole group; phenoxazine group; phenothiazine group; phenazine group; acridine group; dihydrophenazine group; It is one selected from the group consisting of dihydroacridine group; pyridyl group; pyrimidyl group; quinoline group; isoquinoline group; quinazolin group; pyridopyrimidine group; pyridopyrazine group; pyrimidoindole group; and pyridodole group, or has two or more substituents connected.

[0409] In one embodiment of the present specification, L is a direct bond; a substituted or unsubstituted arylene group; or a substituted or unsubstituted divalent heterocyclic group.

[0410] In one embodiment of the present specification, L is a direct bond; a substituted or unsubstituted C6-C30 arylene group; or a substituted or unsubstituted C2-C30 divalent heterocyclic group.

[0411] In one embodiment of the present specification, L is a direct bond; a C6-C30 arylene group; or a C2-C30 divalent heterocyclic group. The arylene group or the divalent heterocyclic group is substituted or unsubstituted with a substituent selected from the group consisting of a nitrile group; a C1-C10 alkyl group; a C6-C30 aryl group; and a C2-C30 heterocyclic group, or with a substituent to which two or more substituents are connected.

[0412] In one embodiment of the present specification, L is a direct bond; a single-ring to five-ring arylene group; or a single-ring to five-ring divalent heterocyclic group. The arylene group or the divalent heterocyclic group is substituted or unsubstituted with a substituent selected from the group consisting of a nitrile group; a C1-C10 alkyl group; a C6-C30 aryl group; and a C2-C30 heterocyclic group, or with a substituent formed by connecting two or more substituents.

[0413] In one embodiment of the present specification, L is a direct bond; a single-ring to four-ring arylene group; or a single-ring to four-ring divalent heterocyclic group. The arylene group or the divalent heterocyclic group is substituted or unsubstituted with a substituent selected from the group consisting of a nitrile group; a C1-C10 alkyl group; a C6-C30 aryl group; and a C2-C30 heterocyclic group, or with a substituent connected to two or more substituents.

[0414] In one embodiment of the present specification, L is a direct bond; a phenylene group; a biphenylene group; a terphenylene group; a naphthylene group; anthracenylene group; a divalent phenanthrenyl group; a divalent triphenylene group; a difluoranthenyl group; a divalent phenalene group; a difluorenyl group; a dimethylfluorenyl group; a divalent carbazole group; a divalent phenylcarbazole group; a divalent benzocarbazole group; a divalent indenocarbazole group; a divalent dibenzothiophene group; a dibenzofuran group; a dibenzosyrol group; a divalent phenoxazine group; a divalent phenothiazine group; a divalent phenazine group; a diacridine group; a dihydrophenazine group; It is a dihydroacridine group; a dihydricyl group; a dihydric pyridyl group; a dihydric pyrimidyl group; a dihydric quinoline group; a dihydric isoquinoline group; a dihydric quinazolin group; a dihydric pyridopyrimidine group; a dihydric pyridopyrazine group; a dihydric pyrimidoindole group; or a dihydric pyridodole group. The above linker (L) is substituted or unsubstituted with one substituent selected from the group consisting of a nitrile group; a C1-C10 alkyl group; a C6-C30 aryl group; and a C2-C30 heterocyclic group, or with a substituent to which two or more substituents are connected.

[0415] In one embodiment of the present specification, L is a direct bond; a C6-C30 arylene group; or a C2-C30 divalent heterocyclic group substituted or unsubstituted with a C1-C6 alkyl group.

[0416] In one embodiment of the present specification, L is a direct bond; a phenylene group; a biphenylene group; a terphenylene group; a naphthylene group; a divalent dibenzothiophene group; a divalent dibenzofuran group; or a dimethyldibenzothyrol group.

[0417] In one embodiment of the present specification, L is a direct bond; a phenylene group; a biphenylene group; or a naphthylene group.

[0418] In one embodiment of the present specification, L is a direct connection.

[0419] In one embodiment of the present specification, m is an integer from 0 to 2.

[0420] In one embodiment of the present specification, m is 0 or 1.

[0421] In one embodiment of the present specification, m is 0.

[0422] In one embodiment of the present specification, r21 is an integer from 0 to 3.

[0423] In one embodiment of the present specification, r22 is an integer from 0 to 3.

[0424] In one embodiment of the present specification, r23 is an integer from 0 to 3.

[0425] In one embodiment of the present specification, r24 is an integer from 0 to 3.

[0426] In one embodiment of the present specification, r21 is an integer from 0 to 2.

[0427] In one embodiment of the present specification, r22 is an integer from 0 to 2.

[0428] In one embodiment of the present specification, r23 is an integer from 0 to 2.

[0429] In one embodiment of the present specification, r24 is an integer from 0 to 2.

[0430] In one embodiment of the present specification, r21 is 1.

[0431] In one embodiment of the present specification, r22 is 1.

[0432] In one embodiment of the present specification, r23 is 1.

[0433] In one embodiment of the present specification, r24 is 1.

[0434] In one embodiment of the present specification, r21 is 0.

[0435] In one embodiment of the present specification, r22 is 0.

[0436] In one embodiment of the present specification, r23 is 0.

[0437] In one embodiment of the present specification, r24 is 0.

[0438] In one embodiment of the present specification, the formula 3 is represented by any one of the following formulas 301 to 303.

[0439] [Chemical Formula 301]

[0440]

[0441] [Chemical Formula 302]

[0442]

[0443] [Chemical Formula 303]

[0444]

[0445] In the above chemical formulas 301 to 303,

[0446] The definitions of L, m, Ar1, and Ar2 are as defined in Chemical Formula 3, and

[0447] At least one of X1 to X3 is N, and the rest are CH or CD, and

[0448] R30 is hydrogen; deuterium; a substituted or unsubstituted alkyl group; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heteroaryl group, and

[0449] r30 is an integer from 0 to 4, and if r30 is 2 or greater, R30 is the same or different from each other.

[0450] In one embodiment of the present specification, in the formula 301, X1 is N or C (R31), X2 is N or C (R32), X3 is N or C (R33), one or more of X1 to X3 are N, and R31, R32 and R33 are the same or different from each other and are each independently hydrogen; deuterium; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heterocyclic group.

[0451] In one embodiment of the present specification, in the formula 301, R31, R32 and R33 are each hydrogen; or deuterium.

[0452] In one embodiment of the present specification, in the formula 301, R31, R32 and R33 are hydrogen.

[0453] In one embodiment of the present specification, the R30 is hydrogen; deuterium; a substituted or unsubstituted C1-10 alkyl group; or a substituted or unsubstituted C6-C30 aryl group; or a substituted or unsubstituted C2-C30 heterocyclic group.

[0454] In one embodiment of the present specification, the R30 is hydrogen; a methyl group; a phenyl group; or a benzocarbazole group.

[0455] In one embodiment of the present specification, R30 is hydrogen; or deuterium.

[0456] In one embodiment of the present specification, R30 is hydrogen.

[0457] In one embodiment of the present specification, the formula 2 is represented by any one of the following formulas 201, 203 and 204.

[0458] [Chemical Formula 201]

[0459]

[0460] [Chemical Formula 203]

[0461]

[0462] [Chemical Formula 204]

[0463]

[0464] In the above chemical formulas 201, 203, and 204,

[0465] The definitions of X1 to X3, L, m, Ar1, Ar2, R21 to R24, r21 to r24 and Y are as defined in Chemical Formula 2, and

[0466] X4 is N or C(R34), X5 is N or C(R35), X6 is N or C(R36), and at least one of X4 to X6 is N, and

[0467] R34, R35, and R36 are identical or different from one another, and each independently is hydrogen; or deuterium, or combines with Ar3 or Ar4 to form a substituted or unsubstituted aromatic hydrocarbon ring; or a substituted or unsubstituted heteroring, and

[0468] Ar3 and Ar4 are identical or different from each other, and each is independently an aryl group substituted or unsubstituted with R43; or a heterocyclic ring substituted or unsubstituted with R44, or an aromatic hydrocarbon ring substituted or unsubstituted by combining with R34, R35, or R36; or forms a substituted or unsubstituted heterocyclic ring, and

[0469] R43 and R44 are identical or different from each other, and each is independently selected from the group consisting of deuterium; halogen group; nitrile group; alkyl group; haloalkyl group; alkoxy group; silyl group; aryl group; and heterocyclic group, or has two or more substituents connected thereto,

[0470] L11 is a directly bonded; a substituted or unsubstituted arylene group; or a substituted or unsubstituted divalent heterocyclic group, and

[0471] m11 is an integer from 0 to 4, and if it is 2 or more, L11 are the same or different from each other.

[0472] In one embodiment of the present specification, of the formulas 201, 203 and 204 and It can be represented by any one of the above chemical formulas 301 to 303.

[0473] In one embodiment of the present specification, the description of L described above may be applied to L11.

[0474] In one embodiment of the present specification, the description of m described above may be applied to m11.

[0475] In one embodiment of the present specification, the description of X1 to X3 described above may be applied to X4 to X6.

[0476] In one embodiment of the present specification, the description of Ar1 and Ar2 described above may be applied to Ar3 and Ar4.

[0477] According to one embodiment of the present specification, the formula 2 is represented by any one of the following formulas 211 to 218.

[0478] [Chemical Formula 211]

[0479]

[0480] [Chemical Formula 212]

[0481]

[0482] [Chemical Formula 213]

[0483]

[0484] [Chemical Formula 214]

[0485]

[0486] In the above chemical formulas 211 to 214,

[0487] The definitions of X1 to X3, L, m, Ar1, Ar2, R21 to R24, r21 to r24 and Y are as defined in Chemical Formula 2.

[0488] In one embodiment of the present specification, the formula 2 is represented by any one of the following formulas 401 to 403.

[0489] [Chemical Formula 401]

[0490]

[0491] [Chemical Formula 402]

[0492]

[0493] [Chemical Formula 403]

[0494]

[0495] In the above chemical formulas 401 to 403,

[0496] The definitions of X1 to X3, L, m, Ar1, Ar2, R23, R24, r23, r24, and Y are as defined in Chemical Formula 2, and

[0497] R25 to R28 are identical or different from one another, and each is independently hydrogen; deuterium; a nitrile group; a substituted or unsubstituted alkyl group; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heterocyclic group, and

[0498] r25 and r28 are each integers from 0 to 6, r26 is an integer from 0 to 5, r27 is an integer from 0 to 3, r28 and r26 are identical or different from each other, and each is independently an integer from 0 to 6, and if r25 is 2 or more, R25 is identical or different from each other, if r26 is 2 or more, R26 is identical or different from each other, if r27 is 2 or more, R27 is identical or different from each other, and if r28 is 2 or more, R28 is identical or different from each other.

[0499] In one embodiment of the present specification, the description of R21 to R24 described above may be applied to R25 to R28.

[0500] According to one embodiment of the present specification, the compound represented by Chemical Formula 2 is any one selected from the following compounds.

[0501]

[0502]

[0503]

[0504]

[0505]

[0506]

[0507]

[0508]

[0509]

[0510]

[0511]

[0512]

[0513]

[0514]

[0515]

[0516]

[0517]

[0518]

[0519]

[0520]

[0521]

[0522]

[0523]

[0524]

[0525]

[0526]

[0527]

[0528]

[0529]

[0530]

[0531]

[0532]

[0533]

[0534]

[0535]

[0536]

[0537] The present specification provides an organic light-emitting device comprising an anode; a cathode; and a first organic layer and a second organic layer provided between the anode and the cathode, wherein the first organic layer comprises a compound represented by Chemical Formula 1 and the second organic layer comprises a compound represented by Chemical Formula 2.

[0538] The organic light-emitting device according to the present specification may include an additional organic layer in addition to the first organic layer and the second organic layer.

[0539] In this specification, when it is stated that a component is located "on" another component, this includes not only cases where a component is in contact with another component, but also cases where another component exists between the two components.

[0540] In this specification, the term "layer" is used in a sense compatible with "film" commonly used in the art and refers to a coating that covers a desired area. The size of the "layer" is not limited, and each "layer" may have the same or different size. In one embodiment, the size of the "layer" may be equal to the size of the entire device, correspond to the size of a specific functional area, or be as small as a single subpixel.

[0541] In the present specification, the meaning of a specific A substance being included in a B layer includes both i) one or more types of A substances being included in a single B layer and ii) the B layer being composed of one or more layers and A substance being included in one or more layers among the multilayer B layers.

[0542] In the present specification, the meaning that a specific A material is included in a C layer or a D layer is that it is included in at least one of the C layers, ii) included in at least one of the D layers, or iii) included in each of the C layers and the D layers.

[0543] The organic layer of the organic light-emitting device of the present specification may be formed as a single layer structure, but may also be formed as a multilayer structure in which two or more organic layers are stacked. For example, it may have a structure including a hole injection layer, a hole transport layer, a light-emitting layer, an electron transport layer, an electron injection layer, an electron blocking layer, a hole blocking layer, etc. However, the structure of the organic light-emitting device is not limited thereto and may include more or fewer organic layers.

[0544] In one embodiment of the present specification, the compound represented by Chemical Formula 1 is included in the first organic layer.

[0545] In one embodiment of the present specification, the first organic layer comprises a hole injection layer, a hole transport layer, a hole control layer, an electron blocking layer, a layer that simultaneously transports and injects holes, or a light-emitting layer.

[0546] In one embodiment of the present specification, the first organic layer is a light-emitting layer.

[0547] In one embodiment of the present specification, the compound represented by Formula 1 is included in an amount of 50 parts by weight or more and less than 100 parts by weight per 100 parts by weight of the first organic layer. More preferably, it is included in an amount of 70 parts by weight or more and 99 parts by weight or less per 100 parts by weight of the first organic layer.

[0548] In one embodiment of the present specification, the light-emitting layer comprises a compound represented by the chemical formula 1 as a host of the light-emitting layer.

[0549] In one embodiment of the present specification, the light-emitting layer comprises a compound represented by the chemical formula 1, and the light-emitting layer comprising the compound represented by the chemical formula 1 has a blue color.

[0550] In one embodiment of the present specification, the light-emitting layer comprising the compound represented by Formula 1 may include a dopant. The dopant may be a fluorescent dopant or a phosphorescent dopant, and a fluorescent dopant is preferred. In this case, the dopant may be included in the light-emitting layer in an amount of 0.1 to 50 parts by weight based on 100 parts by weight of the host, and preferably in an amount of 1 to 30 parts by weight. When the above range is satisfied, energy transfer from the host to the dopant occurs efficiently.

[0551] In one embodiment of the present specification, the light-emitting layer comprising the compound represented by Chemical Formula 1 further comprises a fluorescent dopant.

[0552] In the present invention, the fluorescent dopant may be an aromatic amine derivative or a boron polycyclic compound, and any one of the following structures may be used, but is not limited thereto.

[0553]

[0554] In the present invention, an Ir complex may be used as the phosphorescent dopant, and any one of the following structures may be used as an example, but is not limited thereto.

[0555]

[0556] In one embodiment of the present specification, the organic light-emitting element further comprises one or more light-emitting layers in addition to a light-emitting layer comprising a compound represented by Formula 1. Each of the one or more light-emitting layers may comprise the aforementioned fluorescent dopant or phosphorescent dopant.

[0557] According to one embodiment of the present specification, the organic light-emitting element comprises two or more light-emitting layers, and one of the two or more light-emitting layers comprises a fluorescent dopant and the other layer comprises a phosphorescent dopant.

[0558] According to one embodiment of the present invention, the invention comprises a light-emitting layer comprising a compound represented by the chemical formula 1, wherein the maximum light emission peak of the light-emitting layer is 400 nm to 500 nm.

[0559] In one embodiment of the present specification, the organic light-emitting element comprises two or more light-emitting layers.

[0560] In one embodiment of the present specification, the maximum emission peaks of each emitting layer are different from one another. Specifically, the organic light-emitting device further comprises one or more emitting layers that have a maximum emission peak in a wavelength range different from the wavelength range in which the maximum emission peak of the emitting layer containing one or more compounds represented by Chemical Formula 1 appears.

[0561] The maximum emission peak of the emitting layer containing the compound represented by Chemical Formula 1 above is 400 nm to 500 nm, and the maximum emission peak of the other emitting layer is 510 nm to 580 nm; or may exhibit a maximum emission peak of 610 nm to 680 nm.

[0562] In one embodiment of the present specification, a light-emitting layer other than a light-emitting layer comprising one or more compounds represented by Chemical Formula 1 comprises a phosphorescent dopant. Specifically, one or more light-emitting layers that exhibit a maximum light-emitting peak at a wavelength range different from the wavelength range in which the maximum light-emitting peak of a light-emitting layer comprising one or more compounds represented by Chemical Formula 1 appears comprise a phosphorescent dopant.

[0563] In one embodiment of the present specification, one light-emitting layer may be blue, and the other light-emitting layer may include a blue, red, or green light-emitting compound known in the art.

[0564] According to one embodiment of the present invention, the organic light-emitting element comprises two or more light-emitting layers, one light-emitting layer comprises a fluorescent dopant, and the other light-emitting layer comprises a phosphorescent dopant.

[0565] In addition, when the organic light-emitting device of the present invention includes two or more light-emitting layers, the two or more light-emitting layers may be stacked sequentially in a vertical direction or stacked side by side in a horizontal direction.

[0566] In one embodiment of the present specification, the organic light-emitting device comprises three or more light-emitting layers. In one embodiment, the three or more light-emitting layers are stacked sequentially, and all three or more light-emitting layers may exhibit a maximum light emission peak in the same wavelength range. At this time, the maximum light emission peak is 400 nm to 500 nm, which is a blue region.

[0567] In one embodiment of the present specification, the compound represented by Formula 2 is included in the second organic layer.

[0568] In one embodiment of the present specification, the compound represented by Formula 2 is included in a hole blocking layer, an electron control layer, an electron transport layer, an electron injection layer, or a layer that performs electron transport and injection simultaneously.

[0569] In one embodiment of the present specification, the second organic layer comprises a hole blocking layer, an electron control layer, an electron transport layer, an electron injection layer, or a layer that performs electron transport and injection simultaneously.

[0570] In one embodiment of the present specification, the second organic layer includes an electron transport layer or a layer that performs electron transport and injection simultaneously.

[0571] In one embodiment of the present specification, the first organic layer and the second organic layer are provided in contact.

[0572] In one embodiment of the present specification, a first organic layer is provided between the anode and the cathode. In another embodiment, a second organic layer is provided between the first organic layer and the cathode.

[0573] In one embodiment of the present specification, the second organic layer is provided in contact with the cathode.

[0574] In one embodiment of the present specification, an electron transport region is further included between the second organic layer and the first organic layer.

[0575] In one embodiment of the present specification, the second organic layer further comprises one or more n-type dopants selected from alkali metals and alkaline earth metals in addition to the compound represented by Chemical Formula 2.

[0576] When organoalkali metal compounds or organoalkali earth metal compounds are used as n-type dopants, stability regarding holes in the emissive layer can be secured, thereby improving the lifespan of the organic light-emitting device. Additionally, by controlling the ratio of organoalkali metal compounds or organoalkali earth metal compounds to the electron transport layer, the balance between holes and electrons in the emissive layer can be maximized, thereby increasing luminous efficiency.

[0577] LiQ is more preferred as the n-type dopant used in the second organic layer in this specification. The second organic layer may contain a heterocyclic compound of Formula 2 and the n-type dopant in a weight ratio of 1:9 to 9:1. Preferably, the heterocyclic compound of Formula 1 and the n-type dopant may be contained in a ratio of 2:8 to 8:2, and more preferably in a ratio of 3:7 to 7:3.

[0578] In one embodiment of the present specification, the cathode is a multilayer structure of metal or metal alloy.

[0579] In one embodiment, the organic light-emitting device of the present specification can be manufactured by sequentially stacking a first electrode, an organic layer, and a second electrode on a substrate.

[0580] In one embodiment of the present specification, the first electrode is an anode and the second electrode is a cathode. In another embodiment, the first electrode is a cathode and the second electrode is an anode.

[0581] In one embodiment of the present specification, the organic light-emitting device may be a normal type organic light-emitting device in which an anode, one or more organic layers, and a cathode are sequentially stacked on a substrate.

[0582] In one embodiment of the present specification, the organic light-emitting device may be an inverted type organic light-emitting device in which a cathode, one or more organic layers, and an anode are sequentially stacked on a substrate.

[0583] FIGS. 1 to 4 illustrate the stacked structure of an organic light-emitting device of the present invention.

[0584] FIG. 1 shows an organic light-emitting device sequentially stacked in a vertical direction in the order of a substrate (0), a cathode (1), a second organic layer (202), a first organic layer (201), and an anode (4). In one embodiment of the present specification, the compound represented by Chemical Formula 1 is included in the first organic layer (201), and the compound represented by Chemical Formula 2 is included in the second organic layer (202).

[0585] FIGS. 2 to 4 each show a stacked structure of an organic light-emitting device of the present invention comprising two or more light-emitting layers.

[0586] FIG. 2 shows an organic light-emitting device sequentially stacked in a vertical direction in the order of a substrate (0), a cathode (1), an electron transport layer (2), a hole blocking layer or an electron control layer (7), an emitting layer 1 (11), an organic layer (5), an emitting layer 2 (12), a hole transport layer (3), and an anode (4). In one embodiment of the present specification, the compound represented by Chemical Formula 1 is included in the organic layer (5) or the hole transport layer (3). In one embodiment, the compound represented by Chemical Formula 2 is included in the electron transport layer (2), the hole blocking layer or the electron control layer (7), or the organic layer (5).

[0587] FIG. 3 shows an organic light-emitting device sequentially stacked in a vertical direction in the order of a substrate (0), a cathode (1), an electron transport layer (2), a hole blocking layer or an electron control layer (7), a light-emitting layer 1 (11), an organic layer (5), a light-emitting layer 2 (12), an organic layer (6), a light-emitting layer 3 (13), a hole transport layer (3), and an anode (4). In one embodiment of the present specification, the compound represented by Chemical Formula 1 is included in the organic layer (5), the organic layer (6), or the hole transport layer (3).

[0588] FIG. 4 illustrates an organic light-emitting device in which a substrate (0), a cathode (1), an electron transport layer (2), a hole blocking layer or electron control layer (7), a light-emitting layer (101), a hole transport layer (3), and an anode (4) are stacked in that order, and the light-emitting layer (101) is formed by stacking a light-emitting layer 1 (11) and a light-emitting layer 2 (12) in parallel in a horizontal direction. In one embodiment of the present specification, the compound represented by Chemical Formula 1 is included in the hole transport layer (3). In one embodiment, the compound represented by Chemical Formula 2 is included in the electron transport layer (2) or the hole blocking layer or electron control layer (7).

[0589] In one embodiment, the compound represented by the chemical formula 2 is included in the electron transport layer (2), the hole blocking layer or the electron control layer (7), the organic layer (5) or the organic layer (6). In one embodiment of the present invention, the light emission color of the light-emitting layer 1 (11), the light-emitting layer 2 (12), and the light-emitting layer 3 (13) is the same. In one embodiment, the light-emitting layer 1 (11), the light-emitting layer 2 (12), and the light-emitting layer 3 (13) are blue.

[0590] As shown in FIGS. 2 and 3, when a plurality of light-emitting layers are stacked, the organic layer provided between the plurality of light-emitting layers may be an intermediate layer. The intermediate layer is generally also referred to as an intermediate electrode, an intermediate conductive layer, a charge generating layer, an electron extraction layer, a connection layer, or an intermediate insulating layer. Any known material composition may be used as long as it is a layer that has the function of supplying electrons to an adjacent layer on the anode side and holes to an adjacent layer on the cathode side. In one embodiment of the present invention, the organic layer (5) located between light-emitting layer 1 and light-emitting layer 2 is a charge generating layer or an intermediate insulating layer. In one embodiment of the present invention, the organic layer (6) located between light-emitting layer 2 and light-emitting layer 3 is a charge generating layer or an intermediate insulating layer.

[0591] However, the structure of an organic light-emitting device according to one embodiment of the present specification is not limited to FIGS. 1 to 4 and may be any one of the following structures.

[0592] (1) Anode / hole transport layer / emissive layer / cathode

[0593] (2) Anode / hole injection layer / hole transport layer / emissive layer / cathode

[0594] (3) Anode / hole transport layer / emissive layer / electron transport layer / cathode

[0595] (4) Anode / hole transport layer / emissive layer / electron transport layer / electron injection layer / cathode

[0596] (5) Anode / hole injection layer / hole transport layer / emissive layer / electron transport layer / cathode

[0597] (6) Anode / hole injection layer / hole transport layer / emissive layer / electron transport layer / electron injection layer / cathode

[0598] (7) Anode / hole transport layer / hole control layer / emissive layer / electron transport layer / cathode

[0599] (8) Anode / hole transport layer / hole control layer / emissive layer / electron transport layer / electron injection layer / cathode

[0600] (9) Anode / hole injection layer / hole transport layer / hole control layer / emissive layer / electron transport layer / cathode

[0601] (10) Anode / hole injection layer / hole transport layer / hole control layer / emissive layer / electron transport layer / electron injection layer / cathode

[0602] (11) Anode / hole transport layer / emissive layer / electron control layer / electron transport layer / cathode

[0603] (12) Anode / hole transport layer / emissive layer / electron control layer / electron transport layer / electron injection layer / cathode

[0604] (13) Anode / hole injection layer / hole transport layer / emissive layer / electron control layer / electron transport layer / cathode

[0605] (14) Anode / hole injection layer / hole transport layer / emissive layer 1 / intermediate layer / emissive layer 2 / electron transport layer / electron injection layer / cathode

[0606] (15) Anode / hole injection layer / hole transport layer / emissive layer 1 / intermediate layer / emissive layer 2 / intermediate layer / emissive layer 3 / electron transport layer / electron injection layer / cathode

[0607] In one embodiment of the present invention, the first organic layer is a light-emitting layer, a light-emitting layer 1, a light-emitting layer 2, or a light-emitting layer 3.

[0608] When the above organic light-emitting element includes a plurality of organic layers, the organic layers may be formed of the same material or different materials.

[0609] The organic layer of the above organic light-emitting device can be formed in various ways.

[0610] In one embodiment, an organic light-emitting device can be manufactured by depositing a metal or a conductive metal oxide or an alloy thereof on a substrate to form an anode, forming an organic layer including a hole injection layer, a hole transport layer, a light-emitting layer, and an electron transport layer thereon, and then depositing a material that can be used as a cathode thereon.

[0611] In another embodiment, an organic light-emitting diode may be fabricated by sequentially depositing an organic layer and an anode material from a cathode material onto a substrate (International Patent Application Publication No. 2003 / 012890). However, the manufacturing method is not limited thereto.

[0612] Each organic layer may be formed by any conventional deposition technique, e.g., vapor deposition, liquid deposition (continuous and discontinuous techniques), and thermal transfer. Continuous deposition techniques include, but are not limited to, spin coating, gravure coating, curtain coating, dip coating, slot-die coating, spray coating, and continuous nozzle coating. Discontinuous deposition techniques include, but are not limited to, inkjet printing, gravure printing, and screen printing.

[0613] In one embodiment of the present specification, the first organic layer and the second organic layer may be formed using a physical vapor deposition (PVD) method such as deposition, sputtering, or electron beam evaporation.

[0614] According to another embodiment, the first organic layer and the second organic layer may be formed as organic layers by a solution coating method. Here, the term "solution coating method" refers to spin coating, dip coating, doctor blading, inkjet printing, screen printing, spraying, roll coating, etc., but is not limited to these.

[0615] In one embodiment of the present specification, other layers within the organic light-emitting diode may be manufactured using any known material if they are useful for each layer. Preferred materials suitable for use in the organic layer are exemplified below, but are not limited thereto.

[0616] As the anode material, a material with a large work function is generally preferred to facilitate hole injection into the organic layer. Examples include metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); combinations of metals and oxides such as ZnO:Al or SnO2:Sb; conductive polymers such as poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene](PEDOT), polypyrrole, and polyaniline, but are not limited thereto.

[0617] The above-mentioned cathode material is preferably a material with a small work function to facilitate electron injection into an organic layer. Examples include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, and lead, or alloys thereof; multilayer materials such as LiF / Al or LiO2 / Al, but are not limited thereto.

[0618] The above-mentioned light-emitting layer may include a host material and a dopant material. The host material may include condensed aromatic ring derivatives or heterocyclic compounds. Specifically, condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, fluoranthene compounds, etc., and heterocyclic compounds include dibenzofuran derivatives, ladder-type furan compounds, pyrimidine derivatives, etc., but are not limited thereto.

[0619] The above dopant materials include aromatic amine derivatives, styramine compounds, boron complexes, fluoranthene compounds, metal complexes, etc. Specifically, aromatic amine derivatives are condensed aromatic ring derivatives having substituted or unsubstituted arylamine groups, such as pyrene, anthracene, chrysene, and periplantene having arylamine groups. In addition, styramine compounds are compounds in which at least one arylvinyl group is substituted on a substituted or unsubstituted arylamine, and are substituted or unsubstituted with one or more substituents selected from the group consisting of aryl groups, silyl groups, alkyl groups, cycloalkyl groups, and arylamine groups. Specifically, styramine, styryldiamine, styryltriamine, styryltetraamine, etc. are included, but are not limited thereto. In addition, metal complexes include iridium complexes, platinum complexes, etc., but are not limited thereto.

[0620] The hole injection layer described above is a layer that receives holes from the electrode. It is desirable for the hole injection material to have the ability to transport holes, thereby having an excellent hole receiving effect from the anode and an excellent hole injection effect on the emitting layer or emitting material. In addition, it is desirable for the material to have an excellent ability to prevent the movement of excitons generated in the emitting layer to the electron injection layer or electron injection material. In addition, it is desirable for the material to have an excellent thin film formation ability. Furthermore, it is desirable for the HOMO (highest occupied molecular orbital) of the hole injection material to be between the work function of the anode material and the HOMO of the surrounding organic layer. Specific examples of hole injection materials include, but are not limited to, metal porphyrins, oligothiophenes, arylamine-based organic materials; hexanitrile-hexaazatriphenylene-based organic materials; quinacridone-based organic materials; perylene-based organic materials; and polythiophene-based conductive polymers such as anthraquinone and polyaniline.

[0621] The hole transport layer described above is a layer that receives holes from the hole injection layer and transports them to the emissive layer. As for the hole transport material, a material capable of receiving holes from the anode or the hole injection layer and transferring them to the emissive layer is preferably a material with high mobility for holes. Specific examples include, but are not limited to, arylamine-based organic materials, conductive polymers, and block copolymers containing both conjugated and non-conjugated portions.

[0622] The electron transport layer described above is a layer that receives electrons from the electron injection layer and transports them to the light-emitting layer. As for the electron transport material, it is a material capable of effectively receiving electrons from the cathode and transferring them to the light-emitting layer, and a material with high electron mobility is preferred. Specific examples include, but are not limited to, Al complexes of 8-hydroxyquinoline; complexes containing Alq3; organic radical compounds; and hydroxyflavone-metal complexes. The electron transport layer can be used with any desired cathode material as in the prior art. In particular, a suitable cathode material is a conventional material having a low work function followed by an aluminum layer or a silver layer. Specifically, examples include cesium, barium, calcium, ytterbium, and samarium, each followed by an aluminum layer or a silver layer.

[0623] The electron injection layer is a layer that receives electrons from an electrode. It is desirable for the electron injection material to have excellent electron transport ability and to have an electron receiving effect from the second electrode, as well as an excellent electron injection effect on the emitting layer or emitting material. In addition, it is desirable for the material to prevent excitons generated in the emitting layer from moving to the hole injection layer and to have excellent thin film formation ability. Specifically, examples include fluorenone, anthraquinodimethane, diphenoquinone, thiopyran dioxide, oxazole, oxadiazole, triazole, imidazole, perylenetetracarboxylic acid, preolenylidene methane, anthrone, and their derivatives, metal complex compounds, and nitrogen-containing five-membered ring derivatives, but are not limited thereto.

[0624] The above metal complex compounds include 8-hydroxyquinolinato lithium, bis(8-hydroxyquinolinato)zinc, bis(8-hydroxyquinolinato)copper, bis(8-hydroxyquinolinato)manganese, tris(8-hydroxyquinolinato)aluminum, tris(2-methyl-8-hydroxyquinolinato)aluminum, tris(8-hydroxyquinolinato)gallium, bis(10-hydroxybenzo[h]quinolinato)beryllium, bis(10-hydroxybenzo[h]quinolinato)zinc, bis(2-methyl-8-quinolinato)chlorogallium, bis(2-methyl-8-quinolinato)(o-cresolato)gallium, Bis(2-methyl-8-quinolinato)(1-naphtolato)aluminum, bis(2-methyl-8-quinolinato)(2-naphtolato)gallium, etc., are included but are not limited thereto.

[0625] The above electron blocking layer is a layer capable of improving the lifespan and efficiency of the device by preventing electrons injected from the electron injection layer from passing through the light-emitting layer and entering the hole injection layer. Known materials may be used without limitation and can be formed between the light-emitting layer and the hole injection layer, or between the light-emitting layer and a layer that performs both hole injection and hole transport simultaneously.

[0626] The hole blocking layer described above is a layer that prevents holes from reaching the cathode, and can generally be formed under the same conditions as the electron injection layer. Specifically, oxadiazole derivatives, triazole derivatives, phenanthroline derivatives, aluminum complexes, etc. are used, but are not limited thereto.

[0627] The organic light-emitting device according to the present specification may be a front-emitting type, a back-emitting type, or a double-sided emitting type depending on the material used.

[0628] Hereinafter, to specifically explain this specification, examples will be described in detail. However, the embodiments according to this specification may be modified in various different forms, and the scope of this application is not to be interpreted as being limited to the embodiments described below. The embodiments of this application are provided to more completely explain this specification to those with average knowledge in the art.

[0629] <Synthesized Example 1>

[0630] Synthesis Example 1-1

[0631]

[0632] Preparation of Compound 1-1A

[0633] 9-bromoanthracene (22 g, 95.8 mmol) and phenylboronic acid (10.5 g, 85.9 mmol) were completely dissolved in 1,4-dioxane (300 mL), followed by the addition of 2 M aqueous potassium carbonate solution (100 mL) and tetracysteine ​​triphenylphosphinopalladium (Pd(PPh3)4, 0.2 g, 2 mol%). The mixture was stirred and refluxed for 5 hours. The temperature was lowered to room temperature, the aqueous layer was removed, and the organic layer was dried with anhydrous magnesium sulfate (MgSO4) and filtered. The filtrate was concentrated under reduced pressure and purified by silica gel column chromatography to obtain Compound 1-1A (18.0 g, 82%, MS: [M+H] + = 255) obtained.

[0634] Preparation of Compound 1-1B

[0635] Compound 1-1A (18.0 g, 71 mmol) and AlCl3 (0.5 g) were added to C6D6 (400 ml) and stirred for 2 hours. After the reaction was complete, D2O (60 ml) was added and stirred for 30 minutes, followed by the dropwise addition of trimethylamine (6 ml). The reaction mixture was transferred to a separatory funnel and extracted with water and toluene. The extract was dried with anhydrous magnesium sulfate (MgSO4) and recrystallized with ethyl acetate to obtain Compound 1-1B (13.1 g, 68%, MS: [M+H] + = 269) obtained.

[0636] Preparation of Compound 1-1C

[0637] Compound 1-1B (13 g, 49 mmol), N-bromosuccinimide (NBS, 9.5 g, 53.4 mmol), and 300 ml of dimethylformamide (DMF) were added, and the mixture was stirred at room temperature for 8 hours under an argon atmosphere. After the reaction was complete, the organic layer was extracted with water and ethyl acetate. The extract was dried with anhydrous magnesium sulfate (MgSO4) and filtered. The filtrate was reduced in color and concentrated, and the sample was purified by silica gel column chromatography to obtain Compound 1-1C (12.8 g, 76%, MS: [M+H] + = 346) obtained.

[0638] Preparation of Compound 1-1

[0639] Except for using compound 1-1C instead of 9-bromoanthracene and (4-(naphthalen-1-yl)phenyl)boronic acid instead of phenylboronic acid, compound 1-1 (MS: [M+H]) prepared in the same manner as compound 1-1A. + = 470) obtained.

[0641] Synthesis Example 1-2

[0642]

[0643] Compound 1-2 (MS: [M+H] + = 434) obtained.

[0645] Synthesis Example 1-3

[0646]

[0647] Preparation of Compound 1-3A

[0648] Compound 1-3A (MS: [M+H] + = 381) obtained.

[0649] Preparation of Compound 1-3B

[0650] Except for using Compound 1-3A instead of Compound 1-1A, Compound 1-3B (MS: [M+H]) prepared in the same manner as Compound 1-1B. + = 400) obtained.

[0651] Preparation of Compound 1-3C

[0652] Except for using compound 1-3B instead of compound 1-1B, compound 1-3C (MS: [M+H]) prepared in the same manner as compound 1-1C. + = 477) obtained.

[0653] Preparation of Compounds 1-3

[0654] Compound 1-3 (MS: [M+H]+ = 526) was obtained by the same method as the preparation of compound 1-1A, except that compound 1-3C was used instead of 9-bromoanthracene and naphthalen-2-ylboronic acid was used instead of phenylboronic acid.

[0656] Synthesis Example 1-4

[0657]

[0658] Preparation of Compound 1-4A

[0659] Except for using (7-(naphthalen-1-yl)dibenzo[b,d]furan-2-yl)boronic acid instead of phenylboronic acid, compound 1-4A (MS: [M+H] + = 471) obtained.

[0660] Preparation of Compound 1-4B

[0661] Except for using compound 1-4A instead of compound 1-1A, compound 1-4B (MS: [M+H]) was prepared in the same manner as compound 1-1B. + = 493) obtained.

[0662] Preparation of Compound 1-4C

[0663] Except for using compound 1-4B instead of compound 1-1B, compound 1-4C (MS: [M+H]) prepared in the same manner as compound 1-1C. + = 570) obtained.

[0664] Preparation of Compounds 1-4

[0665] Compound 1-4 (MS: [M+H]+ = 568) was obtained by the same method as the preparation of compound 1-1A, except that compound 1-4C was used instead of 9-bromoanthracene.

[0667] Synthesis Example 1-5

[0668]

[0669] Preparation of Compound 1-5B

[0670] Except for using Compound 1-1A instead of Compound 1-1B, Compound 1-5B (MS: [M+H]) prepared in the same manner as Compound 1-1C. + = 333) obtained.

[0671] Preparation of Compound 1-5C

[0672] Compound 1-5C (MS: [M+H] + = 497) obtained.

[0673] Preparation of Compounds 1-5

[0674] Compound 1-5 (MS: [M+H]+ = 521) was obtained using the same method as for compound 1-1B, except that compound 1-5C was used instead of compound 1-1A.

[0676] Synthesis Example 1-6

[0677]

[0678] Preparation of Compound 1-6A

[0679] Compound 1-6A (MS: [M+H] + = 596) obtained.

[0680] Preparation of Compound 1-6B

[0681] Except for using compound 1-6A instead of compound 1-1B, compound 1-6B (MS: [M+H]) was prepared in the same manner as compound 1-1C. + = 674) obtained.

[0682] Preparation of Compounds 1-6

[0683] Compound 1-6 (MS: [M+H]+ = 757) was obtained by the same method as the preparation of compound 1-1A, except that compound 1-6B was used instead of 9-bromoanthracene and ([1,1'-biphenyl]-4-yl-d9)boronic acid was used instead of phenylboronic acid.

[0685] Synthesis Example 1-7

[0686]

[0687] Preparation of Compound 1-7A

[0688] Compound 1-7A (MS: [M+H] + = 331) obtained.

[0689] Preparation of Compound 1-7B

[0690] Except for using compound 1-7A instead of compound 1-1B, compound 1-7B (MS: [M+H]) was prepared in the same manner as compound 1-1C. + = 409) obtained.

[0691] Preparation of Compound 1-7C

[0692] Compound 1-7C (MS: [M+H]) prepared in the same manner as Compound 1-1A, except that Compound 1-7B was used instead of 9-bromoanthracene and fluoranthen-8-ylboronic acid was used instead of phenylboronic acid. + = 531) obtained.

[0693] Preparation of Compound 1-7

[0694] Compound 1-7 (MS: [M+H]+ = 557) was obtained using the same method as for compound 1-1B, except that compound 1-7C was used instead of compound 1-1A.

[0696] Synthesis Example 1-8

[0697]

[0698] Preparation of Compound 1-8A

[0699] Compound 1-8A (MS: [M+H] + = 332) obtained.

[0700] Preparation of Compound 1-8B

[0701] Except for using compound 1-8A instead of compound 1-1B, compound 1-8B (MS: [M+H]) was prepared in the same manner as compound 1-1C. + = 410) obtained.

[0702] Preparation of Compound 1-8C

[0703] Except for using compound 1-8B instead of compound 1-1A, compound 1-8C (MS: [M+H]) prepared in the same manner as compound 1-1B. + = 426) obtained.

[0704] Preparation of Compound 1-8

[0705] Compound 1-8 (MS: [M+H]+ = 550) was obtained by the same method as the preparation of compound 1-1A, except that compound 1-8C was used instead of 9-bromoanthracene and (3-(naphthalen-1-yl)phenyl)boronic acid was used instead of phenylboronic acid.

[0707] Synthesis Example 1-9

[0708]

[0709] Preparation of Compound 1-9A

[0711] Compound 1-9A (MS: [M+H] + = 305) obtained.

[0712] Preparation of Compound 1-9B

[0713] Except for using compound 1-9A instead of compound 1-1B, compound 1-9B (MS: [M+H]) was prepared in the same manner as compound 1-1C. + = 383) obtained.

[0714] Preparation of Compound 1-9C

[0715] Compound 1-9C (MS: [M+H] + = 521) obtained.

[0716] Preparation of Compound 1-9

[0717] Compound 1-9 (MS: [M+H]+ = 545) was obtained using the same method as for compound 1-1B, except that compound 1-9C was used instead of compound 1-1A.

[0719] Synthesis Example 1-10

[0720]

[0721] Preparation of Compound 1-10C

[0722] Compound 1-10C (MS: [M+H] + = 487) obtained.

[0723] Preparation of Compounds 1-10

[0724] Compound 1-10 (MS: [M+H]+ = 509) was obtained using the same method as for compound 1-1B, except that compound 1-10C was used instead of compound 1-1A.

[0726] Synthesis Example 1-11

[0727]

[0728] Preparation of Compound 1-11B

[0729] Except for using compound 1-9A instead of compound 1-1A, compound 1-11B (MS: [M+H]) was prepared in the same manner as compound 1-1B. + = 321) obtained.

[0730] Preparation of Compound 1-11C

[0731] Except for using compound 1-11B instead of compound 1-1B, compound 1-11C (MS: [M+H]) prepared in the same manner as compound 1-1C. + = 398) obtained.

[0732] Preparation of Compound 1-11

[0733] Compound 1-11 (MS: [M+H]+ = 486) was obtained by the same method as the preparation of compound 1-1A, except that compound 1-11C was used instead of 9-bromoanthracene and dibenzo[b,d]furan-2-ylboronic acid was used instead of phenylboronic acid.

[0735] Synthesis Example 1-12

[0736]

[0737] Preparation of Compound 1-12C

[0738] Compound 1-12C (MS: [M+H]) was prepared in the same manner as Compound 1-1A, except that Compound 1-9B was used instead of 9-bromoanthracene and naphthalen-2-ylboronic acid was used instead of phenylboronic acid. + = 431) obtained.

[0739] Preparation of Compound 1-12

[0740] Compound 1-12 (MS: [M+H]+ = 453) was obtained using the same method as for compound 1-1B, except that compound 1-12C was used instead of compound 1-1A.

[0742] Synthesis Example 1-13

[0743]

[0744] Preparation of Compound 1-13C

[0745] Compound 1-13C (MS: [M+H] + = 623) obtained.

[0746] Preparation of Compound 1-13

[0747] Compound 1-13 (MS: [M+H]+ = 653) was obtained using the same method as for compound 1-1B, except that compound 1-13C was used instead of compound 1-1A.

[0749] Synthesis Example 1-14

[0750]

[0751] Preparation of Compound 1-14A

[0752] Compound 1-14A (MS: [M+H] + = 345) obtained.

[0753] Preparation of Compound 1-14B

[0754] Except for using compound 1-14A instead of compound 1-1B, compound 1-14B (MS: [M+H]) was prepared in the same manner as compound 1-1C. + = 423) obtained.

[0755] Preparation of Compound 1-14C

[0756] Except for using compound 1-14B instead of 9-bromoanthracene, compound 1-14C (MS: [M+H]) prepared in the same manner as compound 1-1A. + = 421) obtained.

[0757] Preparation of Compound 1-14

[0758] Compound 1-14 (MS: [M+H]+ = 441) was obtained using the same method as for compound 1-1B, except that compound 1-14C was used instead of compound 1-1A.

[0760] Synthesis Example 1-15

[0761]

[0762] Preparation of Compound 1-15A

[0763] Compound 1-15A (MS: [M+H] + = 329) obtained.

[0764] Preparation of Compound 1-15B

[0765] Except for using compound 1-15A instead of compound 1-1B, compound 1-15B (MS: [M+H]) prepared in the same manner as compound 1-1C. + = 407) obtained.

[0766] Preparation of Compound 1-15C

[0767] Compound 1-15C (MS: [M+H]) prepared in the same manner as Compound 1-1A, except that Compound 1-15B was used instead of 9-bromoanthracene. + = 405) obtained.

[0768] Preparation of Compound 1-15

[0769] Compound 1-15 (MS: [M+H]+ = 425) was obtained using the same method as for compound 1-1B, except that compound 1-15C was used instead of compound 1-1A.

[0771] Synthesis Example 1-16

[0772]

[0773] Preparation of Compound 1-16A

[0774] Except for using 9-(4-(naphthalen-1-yl)phenyl)anthracene instead of compound 1-1B, compound 1-16A (MS: [M+H] + = 459) obtained.

[0775] Preparation of Compound 1-16B

[0776] Except for using compound 1-16A instead of 9-bromoanthracene and (4-(naphthalen-2-yl)phenyl)boronic acid instead of phenylboronic acid, compound 1-16B (MS: [M+H] + = 583) obtained.

[0777] Preparation of Compound 1-16

[0778] Compound 1-16 (MS: [M+H]+ = 611) was obtained using the same method as for compound 1-1B, except that compound 1-16B was used instead of compound 1-1A.

[0780] Synthesis Example 1-17

[0781]

[0782] Preparation of Compound 1-17A

[0783] Compound 1-17A (MS: [M+H] + = 345) obtained.

[0784] Preparation of Compound 1-17B

[0785] Except for using compound 1-17A instead of compound 1-1A, compound 1-17B (MS: [M+H]) was prepared in the same manner as compound 1-1B. + = 361) obtained.

[0786] Preparation of Compound 1-17C

[0787] Except for using compound 1-17B instead of compound 1-1B, compound 1-17C (MS: [M+H]) was prepared in the same manner as compound 1-1C. + = 438) obtained.

[0788] Preparation of Compound 1-17

[0789] Compound 1-17 (MS: [M+H]+ = 486) was obtained by the same method as the preparation of compound 1-1A, except that compound 1-17C was used instead of 9-bromoanthracene and naphthalen-2-ylboronic acid was used instead of phenylboronic acid.

[0791] <Synthesized Example 2>

[0792] Synthesis Example 2-1

[0793]

[0794] Under a nitrogen stream, spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid (30 g, 79.7 mmol) and 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine (30.2 g, 87.7 mmol) were added to 300 mL of tetrahydrofuran solvent and stirred. An aqueous solution of potassium carbonate (22 g, 159.5 mmol) was added, and the temperature was raised to reflux. Once reflux began, Tetrakis(triphenylphosphine)palladium (O) (2.76 g, 2.39 mmol) was added and stirred for 3 hours. After the reaction was complete, compound 2-1 ([M + H]) was obtained by filtration followed by purification of the ethanol slurry. + = 640) obtained.

[0796] Synthesis Example 2-2

[0797]

[0798] [Compound 2-2]([M + H]) was prepared in the same manner as in Synthesis Example 2-1, except that spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid was used instead of spiro[fluorene-9,9'-xanthen]-3'-ylboronic acid and 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 690).

[0800] Synthesis Example 2-3

[0801]

[0802] [Compound 2-3]([M + H]) was prepared in the same manner as in Synthesis Example 2-1, except that spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid was used instead of spiro[fluorene-9,9'-thioxanthen]-4'-ylboronic acid and 4-(4-bromophenyl)-2-phenylquinazoline was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 629).

[0804] Synthesis Example 2-4

[0805]

[0806] [Compound 2-4]([M + H]) was prepared in the same manner as in Synthesis Example 2-1, except that 1'-bromospiro[fluorene-9,9'-xanthene] was used instead of spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid, and 4,6-diphenyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrimidine was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 639).

[0808] Synthesis Example 2-5

[0809]

[0810] [Compound 2-5]([M + H] was prepared in the same manner as in Synthesis Example 2-1, except that 4-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[fluorene-9,9'-xanthen]-3-yl)benzonitrile was used instead of spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid, and 2-chloro-4-(4-(naphthalen-1-yl)phenyl)-6-phenyl-1,3,5-triazine was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + = 791) was manufactured.

[0812] Synthesis Example 2-6

[0813]

[0814] [Compound 2-6]([M + H] was prepared in the same manner as in Synthesis Example 2-1, except that 2-bromo-4-(3-(2,6-dimethylpyridin-3-yl)phenyl)-6-phenyl-1,3,5-triazine was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 669).

[0816] Synthesis Example 2-7

[0817]

[0818] [Compound 2-7]([M + H] was prepared in the same manner as in Synthesis Example 2-1, except that 4,4,5,5-tetramethyl-2-(spiro[dibenzo[c,h]xanthene-7,9'-fluoren]-5-yl)-1,3,2-dioxaborolane was used instead of spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid, and 4-chloro-2,6-diphenylpyrimidine was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 663).

[0820] Synthesis Example 2-8

[0821]

[0822] [Compound 2-8]([M + H] was prepared in the same manner as in Synthesis Example 2-1, except that 4-([1,1'-biphenyl]-4-yl)-2-(2-chlorospiro[dibenzo[c,h]thioxanthene-7,9'-fluoren]-4-yl)quinazoline was used instead of spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid, and (3-cyanophenyl)boronic acid was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 830).

[0824] Synthesis Example 2-9

[0825]

[0826] [Compound 2-9]([M + H]) prepared in the same manner as in Synthesis Example 2-3, except that 2-(2-bromopyridin-3-yl)-4,6-diphenyl-1,3,5-triazine was used instead of 4-(4-bromophenyl)-2-phenylquinazoline.+ Manufactured = 657).

[0828] Synthesis Example 2-10

[0829]

[0830] [Compound 2-10]([M + H]) prepared in the same manner as in Synthesis Example 2-1, except that 3'-(4-chloro-6-phenyl-1,3,5-triazin-2-yl)-[1,1'-biphenyl]-4-carbonitrile was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 665).

[0832] Synthesis Example 2-11

[0833]

[0834] [Compound 2-11]([M + H]) was prepared in the same manner as in Synthesis Example 2-1, except that 3'-(3'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[fluorene-9,9'-xanthen]-6'-yl)-[1,1'-biphenyl]-3-carbonitrile was used instead of spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid, and 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + = 817) was manufactured.

[0836] Synthesis Example 2-12

[0837]

[0838] [Compound 2-12]([M + H]) was prepared in the same manner as in Synthesis Example 2-1, except that spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid was used instead of spiro[fluorene-9,9'-xanthen]-4'-ylboronic acid and 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine was used instead of 2-bromo-4-(3-(fluoranthen-3-yl)phenyl)-6-phenyl-1,3,5-triazine. + Manufactured = 764).

[0840] Synthesis Example 2-13

[0841]

[0842] [Compound 2-13]([M + H] was prepared in the same manner as in Synthesis Example 2-1, except that 9-(4-(6-chloro-2-phenylpyrimidin-4-yl)phenyl)-9H-carbazole was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 728).

[0845] Synthesis Example 2-14

[0846]

[0847] [Compound 2-14]([M + H]) was prepared in the same manner as in Synthesis Example 2-1, except that 6'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[fluorene-9,9'-xanthene]-3'-carbonitrile was used instead of spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid, and 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 665).

[0849] Synthesis Example 2-15

[0850]

[0851] [Compound 2-15]([M + H] was prepared in the same manner as in Synthesis Example 2-1, except that 4,4,5,5-tetramethyl-2-(spiro[fluorene-9,9'-xanthen]-2'-yl)-1,3,2-dioxaborolane was used instead of spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid, and 3'-(4-(dibenzo[b,d]furan-1-yl)-6-phenyl-1,3,5-triazin-2-yl)-[1,1'-biphenyl]-3-yl 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 806).

[0853] Synthesis Example 2-16

[0854]

[0855] [Compound 2-17]([M + H] was prepared in the same manner as in Synthesis Example 2-1, except that spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid was used instead of spiro[fluorene-9,9'-xanthen]-1'-ylboronic acid and 8-(3-(4-chloro-6-phenyl-1,3,5-triazin-2-yl)phenyl)quinoline was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + = 691) was manufactured.

[0857] Synthesis Example 2-17

[0858]

[0859] [Compound 2-18]([M + H] was prepared in the same manner as in Synthesis Example 2-1, except that 7-(4-(4-chloro-6-phenyl-1,3,5-triazin-2-yl)phenyl)-7H-benzo[c]carbazole was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 779).

[0861] Synthesis Example 2-18

[0862]

[0863] [Compound 2-19]([M + H]) was prepared in the same manner as in Synthesis Example 2-1, except that spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid was used instead of spiro[fluorene-9,9'-xanthen]-3'-ylboronic acid and 4-chloro-6-(3-(phenanthren-9-yl)phenyl)-2-phenylpyrimidine was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 739).

[0865] Synthetic Example 2-19

[0866]

[0867] [Compound 2-20]([M + H] + Manufactured = 755).

[0869] Synthesis Example 2-20

[0870]

[0871] [Compound 2-21]([M + H] was prepared in the same manner as in Synthesis Example 2-1, except that 3'-(4-(1H-phenalen-5-yl)-6-phenyl-1,3,5-triazin-2-yl)-[1,1'-biphenyl]-3-yl 1,1,2,2,3,4,4,4-octafluoro-3-methylbutane-1-sulfonate was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 804).

[0873] Synthesis Example 2-21

[0874]

[0875] [Compound 2-22]([M + H] + = 691) was manufactured.

[0877] Synthesis Example 2-22

[0878]

[0879] [Compound 2-23]([M + H]) was prepared in the same manner as in Synthesis Example 2-1, except that (1,2,3-trimethylspiro[fluorene-9,9'-xanthen]-4'-yl)boronic acid was used instead of spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid, and 4-(7-bromodibenzo[b,d]furan-4-yl)-2,6-diphenylpyrimidine was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. +Manufactured = 771).

[0880] Synthesis Example 2-23

[0881]

[0882] [Compound 2-24]([M + H]) was prepared in the same manner as in Synthesis Example 2-1, except that 4-(3'-butyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid was used instead of spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid, and 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. + Manufactured = 850).

[0884] Synthesis Example 2-24

[0885]

[0886] [Compound 2-25]([M + H] was prepared in the same manner as in Synthesis Example 2-1, except that (2-(naphthalen-1-yl)spiro[fluorene-9,9'-xanthen]-3'-yl)boronic acid was used instead of spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid, and 2-(6-bromo-5,5-dimethyl-5H-dibenzo[b,d]silol-4-yl)-4,6-diphenyl-1,3,5-triazine was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 898).

[0888] Synthesis Example 2-25

[0889]

[0890] [Compound 2-26]([M + H]) was prepared in the same manner as in Synthesis Example 2-1, except that spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid was used instead of spiro[fluorene-9,9'-thioxanthen]-2'-ylboronic acid, and 3-(4,6-bis(4-(trifluoromethoxy)phenyl)-1,3,5-triazin-2-yl)phenyl 1,1,2,2,3,4,4,4-octafluoro-3-methylbutane-1-sulfonate was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 824).

[0892] Synthesis Example 2-26

[0893]

[0894] [Compound 2-27]([M + H]) was prepared in the same manner as in Synthesis Example 2-1, except that spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid was used instead of spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid and 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. + Manufactured = 795).

[0896] Synthesis Example 2-27

[0897]

[0898] [Compound 2-28]([M + H] was prepared in the same manner as in Synthesis Example 2-1, except that 2-(9-(3-chlorospiro[fluorene-9,9'-thioxanthen]-3'-yl)dibenzo[b,d]furan-4-yl)-4,6-diphenyl-1,3,5-triazine was used instead of spiro[fluorene-9,9'-xanthen]-2'-ylboronic acid, and 2,4-diphenyl-6-(8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)dibenzo[b,d]thiophen-3-yl)-1,3,5-triazine was used instead of 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine. + Manufactured = 1159).

[0900] <Example 1-1>

[0901] A glass substrate (Corning 7059 glass) coated with a 100 nm thick thin film of ITO (Indium Tin Oxide) was placed in distilled water containing a dissolved dispersant and cleaned using ultrasound. A detergent from Fischer Co. was used, and distilled water that had been double-filtered through a Millipore Co. filter was used. After washing the ITO for 30 minutes, ultrasonic cleaning was performed for 10 minutes, repeating the process twice with distilled water. After the distilled water washing was completed, ultrasonic cleaning was performed in the order of isopropyl alcohol, acetone, and methanol solvents, followed by drying.

[0902] A hole injection layer with a thickness of 50 nm was formed by thermal vacuum deposition of hexanitrile hexaazatriphenylene (HAT-CN) on the prepared ITO transparent electrode.

[0903] A hole transport layer with a thickness of 40 nm was formed by vacuum depositing compound HT1, a material that transports holes, on top of it.

[0904] A 30 nm thick light-emitting layer was formed by vacuum depositing compound 1-1 and compound D1 in a weight ratio of 25:1 on the hole transport layer.

[0905] A 3 nm thick electronic control layer was formed by vacuum depositing compound ET1 on the above-mentioned light-emitting layer.

[0906] A 35 nm thick electron injection and transport layer was formed by vacuum depositing compound 2-1 and compound LiQ (Lithium Quinolate) in a weight ratio of 1:1 on the above electron control layer.

[0907] An organic light-emitting diode was manufactured by sequentially depositing lithium fluoride (LiF) and aluminum to thicknesses of 1.2 nm and 200 nm on the electron injection and transport layers to form a cathode.

[0908] In the above process, the deposition rate of the organic material was maintained at 0.04 nm / sec to 0.07 nm / sec, the deposition rate of lithium fluoride was maintained at 0.03 nm / sec, the deposition rate of aluminum was maintained at 0.2 nm / sec, and the vacuum level during deposition was 2 × 10 -7 torr to 5 x 10 -6 maintained torr.

[0909]

[0911] <Examples 1-2 to 1-12 and 2-1 to 2-12>

[0912] An organic light-emitting diode was prepared in the same manner as in Example 1-1, except that the compounds of Table 1 below were used instead of compounds 1-1 and 2-1.

[0913]

[0914]

[0915]

[0916]

[0918] <Comparative Examples 1-1 to 1-5 and 2-1 to 2-7>

[0919] An organic light-emitting diode was prepared in the same manner as in Example 1-1, except that the compounds of Table 1 below were used instead of compounds 1-1 and 2-1.

[0920]

[0921]

[0923] For each of the organic light-emitting diodes of the examples and comparative examples, 10 mA / cm 2 The driving voltage and luminous efficiency were measured at a current density of 20 mA / cm². 2 The time (LT98) at which the luminance becomes 98% of the initial luminance at a current density was measured. The results are shown in Tables 1 and 2 below.

[0925] light-emitting layer Electron injection and transport layer Voltage (V) Current efficiency (cd / A) Color coordinates (x,y) LT98(h) Example 1-1 Compound 1-1 Compound 2-2 3.89 4.61 (0.140, 0.126) 161 Examples 1-2 Compound 1-3 Compound 2-1 3.91 4.57 (0.140, 0.126) 176 Examples 1-3 Compound 1-6 Compound 2-6 3.91 4.62 (0.140, 0.126) 162 Examples 1-4 Compound 1-7 Compound 2-5 3.93 4.55 (0.140, 0.126) 194 Examples 1-5 Compound 1-12 Compound 2-10 3.88 4.57 (0.140, 0.126) 172 Examples 1-6 Compound 1-15 Compound 2-14 3.92 4.60 (0.140, 0.126) 178 Examples 1-7 Compound 1-16 Compound 2-15 3.94 4.54 (0.140, 0.126) 175 Examples 1-8 Compound 1-7 Compound 2-28 3.96 4.49 (0.140, 0.126) 168 Examples 1-9 Compound 1-3 Compound 2-19 3.86 4.61 (0.140, 0.126) 175 Examples 1-10 Compound 1-1 Compound 2-23 3.84 4.66 (0.140, 0.126) 165 Example 1-11 Compound 1-12 Compound 2-24 3.87 4.63 (0.140, 0.126) 184 Examples 1-12 Compound 1-16 Compound 2-13 3.93 4.59 (0.140, 0.126) 173 Comparative Example 1-1 HA Compound 2-25 4.09 4.35 (0.140, 0.127) 106 Comparative Example 1-2 HB Compound 2-21 4.06 4.38 (0.141, 0.127) 101 Comparative Examples 1-3 Compound 1-15 ET-C 4.18 4.10 (0.140, 0.127) 123 Comparative Examples 1-4 Compound 1-1 ET-E 4.13 4.08 (0.140, 0.127) 118 Comparative Examples 1-5 HA ET-F 4.25 3.97 (0.141, 0.127) 98

[0926] From Table 1 above, it was confirmed that when the compound of Formula 2, which has high efficiency characteristics, and the compound of Formula 1, which has low voltage and long life characteristics with deuterium substitution, are used together, the deficient characteristics of the compound of Formula 1 and the compound of Formula 2 are mutually complemented, making it possible to realize an even better device.

[0927] light-emitting layer Electron injection and transport layer Voltage (V) Current efficiency (cd / A) Color coordinates (x,y) LT98(h) Example 2-1 Compound 1-2 Compound 2-19 3.79 4.65 (0.140, 0.126) 174 Example 2-2 Compound 1-4 Compound 2-12 3.75 4.61 (0.140, 0.126) 179 Examples 2-3 Compound 1-5 Compound 2-20 3.68 4.67 (0.140, 0.126) 184 Examples 2-4 Compound 1-8 Compound 2-18 3.76 4.59 (0.140, 0.126) 178 Examples 2-5 Compound 1-9 Compound 2-26 3.80 4.62 (0.140, 0.126) 175 Examples 2-6 Compound 1-10 Compound 2-27 3.78 4.60 (0.140, 0.126) 178 Examples 2-7 Compound 1-11 Compound 2-11 3.75 4.67 (0.140, 0.126) 183 Examples 2-8 Compound 1-13 Compound 2-9 3.79 4.58 (0.140, 0.126) 191 Examples 2-9 Compound 1-14 Compound 2-17 3.69 4.63 (0.140, 0.126) 186 Example 2-10 Compound 1-5 Compound 2-4 3.73 4.61 (0.140, 0.126) 188 Example 2-11 Compound 1-10 Compound 2-3 3.83 4.56 (0.140, 0.126) 176 Example 2-12 Compound 1-14 Compound 2-7 3.75 4.60 (0.140, 0.126) 178 Comparative Example 2-1 HD Compound 2-8 4.10 4.26 (0.140, 0.127) 109 Comparative Example 2-2 HE Compound 2-26 4.07 4.34 (0.140, 0.127) 111 Comparative Example 2-3 Compound 1-10 ET-B 4.14 4.02 (0.140, 0.127) 122 Comparative Example 2-4 Compound 1-4 ET-D 4.11 4.07 (0.140, 0.126) 125 Comparative Example 2-5 Compound 1-8 ET-A 4.15 3.99 (0.140, 0.127) 116 Comparative Example 2-6 HC ET-D 4.23 3.99 (0.140, 0.127) 100 Comparative Example 2-7 HE ET-B 4.17 4.04 (0.140, 0.126) 103

[0928] As shown in Table 1 above, it was confirmed from Table 2 that the deficient characteristics of the compound of Formula 1 and the compound of Formula 2 are mutually complemented, making it possible to realize an even more superior device. In particular, the comparative example compound HE has the same structure as Formula 1, but the deuterium substitution rate is less than 40%, so it can be seen that the lifespan characteristics are inferior compared to the device of the present invention. In addition, compounds 1-2, 1-4, 1-5, 1-9 to 1-11, 1-13, and 1-14 in Table 2 are Ar101 or Ar102 containing heteroaryl groups (dibenzofuran groups, naphthobenzofuran groups, or dibenzothiophene groups), and it can be seen that the long lifespan characteristics are further improved compared to those containing only aryl groups. Explanation of the symbols

[0929] 0: Substrate 1: Cathode 2: Electron transport layer 3: Precision Transport Layer 4: Positive electrode 5: Organic layer 6: Organic layer 7: Hole blocking layer or electron control layer 11: Emitting layer 1 12: Emitting layer 2 13: Emitting layer 3 101: Emitting layer 201: First organic layer 202: Second organic layer

Claims

Claim 1 An organic light-emitting device comprising an anode; a cathode; a first organic layer and a second organic layer provided between the anode and the cathode, wherein the first organic layer comprises a compound represented by the following chemical formula 1 and the second organic layer comprises a compound represented by the following chemical formula 2: [Chemical Formula 1] In the above Chemical Formula 1, L101 and L102 are identical or different from each other, and each is independently directly bonded; a substituted or unsubstituted arylene group; or a substituted or unsubstituted heteroarylene group; R11 to R18 are deuterium; one of Ar101 and Ar102 is a substituted or unsubstituted naphthobenzofuran group; a substituted or unsubstituted quinoline group; or a substituted or unsubstituted pyridine group, and the other is a substituted or unsubstituted C6-C20 aryl group or forms a substituted or unsubstituted ring by connecting with an adjacent substituent; m1 and m2 are integers from 0 to 5; if m1 is 2 or more, L101 are identical or different from each other; if m2 is 2 or more, L102 are identical or different from each other; and the compound represented by the above Chemical Formula 1 is deuteriden by at least 40% or more, [Chemical Formula 2] In the above Chemical Formula 2, Y is O; or S, and R21 to R24 are identical or different from each other and are each independently hydrogen; deuterium; a nitrile group; a substituted or unsubstituted alkyl group; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heterocyclic group, represented by the following Chemical Formula 3, or adjacent substituents are bonded to each other to form a substituted or unsubstituted ring, and at least one of R21 and R22 is represented by the following Chemical Formula 3, and r21 to r24 are identical or different from each other and are each independently integers from 0 to 4, and if r21 is 2 or more, R21 are identical or different from each other, if r22 is 2 or more, R22 are identical or different from each other, if r23 is 2 or more, R23 are identical or different from each other, and if r24 is 2 or more, R24 are identical or different from each other, [Chemical Formula 3] In the above chemical formula 3, X1 is N or C (R31), X2 is N or C (R32), X3 is N or C (R33), and at least one of X1 to X3 is N; R31, R32, and R33 are identical or different from each other and each independently forms hydrogen; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heterocyclic ring, or a substituted or unsubstituted aromatic hydrocarbon ring combined with Ar1 or Ar2; or a substituted or unsubstituted heterocyclic ring; Ar1 ​​and Ar2 are identical or different from each other and each independently forms an aryl group substituted or unsubstituted with R41; or a heterocyclic ring substituted or unsubstituted with R42; or a substituted or unsubstituted aromatic hydrocarbon ring combined with R31, R32, or R33; or a substituted or unsubstituted heterocyclic ring; and R41 and R42 are identical or different from each other and each independently forms deuterium; It is one selected from the group consisting of a halogen group; a nitrile group; an alkyl group; a haloalkyl group; an alkoxy group; a silyl group; an aryl group; and a heterocyclic group, or is connected to two or more substituents, L is a direct bond; a substituted or unsubstituted arylene group; or a substituted or unsubstituted divalent heterocyclic group, m is an integer from 0 to 4, and if m is 2 or more, L is the same or different from each other, and * is the site that is bonded to Formula 2. Claim 2 An organic light-emitting device according to claim 1, wherein the chemical formula 3 is represented by any one of the following chemical formulas 301 to 303: [Chemical Formula 301] [Chemical Formula 302] [Chemical Formula 303] In the above formulas 301 to 303, the definitions of L and m are as defined in formula 3, Ar1 and Ar2 are identical or different from each other and are each independently an aryl group substituted or unsubstituted with R41; or a heterocyclic group substituted or unsubstituted with R42, R41 and R42 are identical or different from each other and are each independently selected from the group consisting of deuterium; halogen group; nitrile group; alkyl group; haloalkyl group; alkoxy group; silyl group; aryl group; and heterocyclic group, or have two or more substituents connected, one or more of X1 to X3 are N, and the remainder are CH or CD, R30 is hydrogen; deuterium; a substituted or unsubstituted alkyl group; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heteroaryl group, r30 is an integer from 0 to 4, and if r30 is 2 or more, R30 are identical or different from each other. Claim 3 An organic light-emitting device according to claim 1, wherein the chemical formula 2 is represented by any one of the following chemical formulas 201, 203, and 204: [Chemical Formula 201] [Chemical Formula 203] [Chemical Formula 204] In the above chemical formulas 201, 203, and 204, the definitions of X1 to X3, L, m, Ar1, Ar2, R21 to R24, r21 to r24, and Y are as defined in chemical formula 2, X4 is N or C (R34), X5 is N or C (R35), X6 is N or C (R36), at least one of X4 to X6 is N, R34, R35, and R36 are identical or different from each other and are each independently hydrogen or deuterium, or form an aromatic hydrocarbon ring that is substituted or unsubstituted by combining with Ar3 or Ar4; or form a substituted or unsubstituted heteroring, where Ar3 and Ar4 are identical or different from each other and are each independently substituted or unsubstituted with R43; or a heterocyclic ring substituted or unsubstituted with R44, or an aromatic hydrocarbon ring substituted or unsubstituted by combining with R34, R35, or R36; or forming a substituted or unsubstituted heterocyclic ring, wherein R43 and R44 are identical or different from each other, and each is independently selected from the group consisting of deuterium; halogen group; nitrile group; alkyl group; haloalkyl group; alkoxy group; silyl group; aryl group; and heterocyclic ring, or is connected with two or more substituents, and L11 is a direct bond; a substituted or unsubstituted arylene group; or a substituted or unsubstituted divalent heterocyclic ring, and m11 is an integer from 0 to 4, and if it is 2 or more, L11 is identical or different from each other. Claim 4 An organic light-emitting device according to claim 1, wherein the chemical formula 2 is represented by any one of the following chemical formulas 211 to 214: [Chemical Formula 211] [Chemical Formula 212] [Chemical Formula 213] [Chemical Formula 214] In the above chemical formulas 211 to 214, the definitions of X1 to X3, L, m, Ar1, Ar2, R21 to R24, r21 to r24 and Y are as defined in chemical formula 2. Claim 5 An organic light-emitting device according to claim 1, wherein the chemical formula 2 is represented by any one of the following chemical formulas 401 to 403: [Chemical Formula 401] [Chemical Formula 402] [Chemical Formula 403] In the above chemical formulas 401 to 403, the definitions of X1 to X3, L, m, Ar1, Ar2, R23, R24, r23, r24, and Y are as defined in chemical formula 2, and R25 to R28 are identical or different from one another and each independently hydrogen; deuterium; a nitrile group; a substituted or unsubstituted alkyl group; a substituted or unsubstituted aryl group; or is a substituted or unsubstituted heterocyclic ring, r25 and r28 are each integers from 0 to 6, r26 is an integer from 0 to 5, r27 is an integer from 0 to 3, r28 and r26 are identical or different from each other, and each is independently an integer from 0 to 6, where r25 is 2 or more, R25 is identical or different from each other, where r26 is 2 or more, R26 is identical or different from each other, where r27 is 2 or more, R27 is identical or different from each other, and where r28 is 2 or more, R28 is identical or different from each other. Claim 6 An organic light-emitting device according to claim 1, wherein the compound represented by Chemical Formula 1 is a compound that is 60% or more deuterated. Claim 7 An organic light-emitting device according to claim 1, wherein the compound represented by Chemical Formula 1 is any one selected from the following compounds M25, M30, and M33: [Compound M25] (In compound M25, the value of x + y + z + p is 16 to 22.)[Compound M30] (In Compound M30, the value of x + y + z is 12 to 24.)[Compound M33] (In compound M33, the value of x + y + z + p + n is 15 to 30.) Claim 8 An organic light-emitting device according to claim 1, wherein the compound represented by Chemical Formula 1 is any one selected from the following compounds: . Claim 9 An organic light-emitting device according to claim 1, wherein the compound represented by Chemical Formula 2 is any one selected from the following compounds: . Claim 10 An organic light-emitting device according to claim 1, wherein the first organic layer is a light-emitting layer. Claim 11 An organic light-emitting device according to claim 1, wherein the first organic layer is a light-emitting layer, the light-emitting layer comprises a host material, and the host material comprises a compound represented by the chemical formula 1. Claim 12 An organic light-emitting device according to claim 10, wherein the organic light-emitting device further comprises one or more light-emitting layers. Claim 13 The organic light-emitting device of claim 10 further comprises one or more light-emitting layers having a maximum light-emitting peak in a wavelength range different from the wavelength range in which a maximum light-emitting peak appears of a light-emitting layer comprising one or more compounds represented by the chemical formula 1. Claim 14 An organic light-emitting device according to claim 10, wherein the light-emitting layer comprising the compound represented by Chemical Formula 1 further comprises a fluorescent dopant. Claim 15 An organic light-emitting device according to claim 13, wherein one or more light-emitting layers, each having a maximum emission peak in a wavelength range different from the wavelength range in which a maximum emission peak appears in a light-emitting layer comprising one or more compounds represented by Chemical Formula 1, comprise a phosphorescent dopant.

Citation Information

Patent Citations

  • Deuterated anthracene derivative and organic light emitting device comprising the same

    KR1020100069216A

  • Organic electroluminescent element

    KR1020170130434A

  • Organic light emitting device

    KR1020180103021A